Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Multiple Sclerosis: HELP
Gavin Giovannoni
Based on 220 articles published since 2008
||||
Expertise Level
The expertise of Gavin Giovannoni ranks in the
  • Top 0.0076%
  • ... of 52,380 published authors worldwide on Multiple Sclerosis
  • ... from 2008 through 2018
  • ... based on contributions to 220 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Giovannoni, Gavin   ·   Giovannoni, G
Work Locations
Details
Most likely:    University of London      
2018
  • Department of Neurology, St George's Hospital NHS Trust, London, UK. · Centre for Clinical Neurosciences, St George's University, London, UK. · Department of Neurology, King's College Hospital NHS Trust, London, UK. · Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. · Blizard Institute, Queen Mary University, London, UK. · Pubmed 28947637
  • Department of Neurology, St. George's Hospital, London, UK. · Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London, UK. · Department of Neurophysiology, Kings College Hospital, London, UK. · Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London, UK. · Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, UK. · Pubmed 29204963
2017
  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK. · Pubmed 29168160
  • Department of Neuroscience and Trauma, Blizard Institute, Queen Mary University of London, London, UK. · Pubmed 28537780
  • Centre for Neuroscience and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK/Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. · Novartis Pharma AG, Basel, Switzerland. · Oxford PharmaGenesis, Oxford, UK. · Department of Neurology and Center of Clinical Neuroscience, Charles University, Prague, Czech Republic/First Faculty of Medicine, Charles University, Prague, Czech Republic/General University Hospital, Prague, Czech Republic. · Pubmed 28381105
  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. Electronic address: · Department of Biostatistics, University of Alabama at Birmingham School of Public Health, Birmingham, AL, USA. Electronic address: · Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · Biogen, Cambridge, MA, USA. Electronic address: · Biogen, Cambridge, MA, USA. Electronic address: · Teva Pharmaceuticals, Netanya, Israel. Electronic address: · Novartis Pharma AG, Basel, Switzerland. Electronic address: · Novartis Pharma AG, Basel, Switzerland. Electronic address: · University of Mississippi Medical Center, Jackson, MS, USA. Electronic address: · NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Queen Square, London, UK. Electronic address: · NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Queen Square, London, UK; NIHR University College Hospitals Biomedical Research Centre (BRC), UK. Electronic address: · Wolfson Institute for Biomedical Research, UCL, London, UK. Electronic address: · Merck, Aubonne, Switzerland. Electronic address: · Merck, Aubonne, Switzerland. Electronic address: · Department of Medicine, Imperial College, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. Electronic address: · Pubmed 28283111
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AT, United Kingdom. · Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AT, United Kingdom. Electronic address: · Pubmed 28161400
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom. Electronic address: · Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom. · Pubmed 29141806
  • Centre for Neuroscience and Trauma, Blizard Institute, Queen Mary University of London, England. · Emergency Care and Acute Medicine, Clinical Academic Group Neuroscience, Barts Health NHS (National Health Service) Trust, The Royal London Hospital, London, England. · Pubmed 28604916
  • Department of Neurology, First Faculty of Medicine, Charles University, Prague, Czech Republic. · Queen Mary University of London, Blizard Institute, London, UK. · St Josef Hospital, Ruhr University, Bochum, Germany. · Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. · Neurologic Clinic and Policlinic, University Hospital, Basel, Switzerland. · Multiple Sclerosis Program, Baylor Institute for Immunology Research, Dallas, TX, USA. · Biogen, Cambridge, MA, USA. · Pubmed 28328179
  • Department of Neurology, Hospital Universitario Quirónsalud, Madrid, Spain. · Virginia Mason Hospital & Seattle Medical Center, Seattle, WA, USA. · Multiple Sclerosis Center of Greater Washington, Vienna, VA, USA. · MS Center, Department of Neurology, First Faculty of Medicine, Charles University, Prague, Czech Republic. · Sanofi Genzyme, Cambridge, MA, USA. · Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Pubmed 27885061
  • Blizard Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London, London E1 2AT, UK. · Pubmed 29143582
  • Department of Neurology, University of Utah, Neurovirology Research Laboratory VASLCHCS, Imaging and Neuroscience Center, 175 North Medical Drive East, Salt Lake City, UT 84132, USA. Electronic address: · Department of Neurology, Queen Mary University London, The London School of Medicine and Dentistry, 4 Newark St, London, England, United Kingdom. Electronic address: · Department of Neurology, University of Münster, Schlossplatz 2, 48149 Münster, Germany. Electronic address: · Department of Neurology, Ruhr-University Bochum, Gudrunstr. 56, 44791 Bochum, Germany. Electronic address: · Department of Neurology, First Faculty of Medicine, Charles University in Prague, Kateřinská 30, 12821 Prague, Czech Republic. Electronic address: · Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research, Biomedicine, and Biomedical Engineering, University of Basel, Petersgraben 4, 4031 Basel, Switzerland. Electronic address: · Department of Neurology, Medical University of Łódź, Al. Kościuszki 4, 90-419 Łódź, Poland. Electronic address: · AbbVie Inc., 1400 Sheridan Rd, North Chicago, IL 60064, USA. Electronic address: · Biogen, 225 Binney St, Cambridge, MA 02142, USA. Electronic address: · AbbVie Biotherapeutics Inc., 1500 Seaport Blvd, Redwood City, CA 94063, USA. Electronic address: · AbbVie Inc., 1400 Sheridan Rd, North Chicago, IL 60064, USA. Electronic address: · Pubmed 29055471
  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK. Electronic address: · Emergency Care and Acute Medicine, Neuroscience Clinical Academic Group, Barts Health NHS Trust, London, UK. · The Agency of Design, 40 Martell Rd, London SE21 8EN, UK. · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Emergency Care and Acute Medicine, Neuroscience Clinical Academic Group, Barts Health NHS Trust, London, UK. · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK. · Pubmed 29055452
  • Department of Neurology, Instituto de Investigación Biomédica de Málaga, Hospital Regional Universitario, Málaga University, Málaga, Spain. · Blizard Institute, Queen Mary University of London, London, United Kingdom. · Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio. · St. Josef Hospital, Ruhr University Bochum, Bochum, Germany. · Multiple Sclerosis Program, Baylor Institute for Immunology Research, Dallas, Texas, USA. · Biogen, Cambridge, Massachusetts, USA. · Biogen, Cambridge, Massachusetts, USA. Electronic address: · Pubmed 28751099
  • Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, Building 10, Room CRC 3-2563, Bethesda, MD, 20892, USA. · Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, Building 10, Room CRC 3-2563, Bethesda, MD, 20892, USA. · Centre for Neuroscience and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK. · Translational Neuroscience Center, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, 20892, USA. · Undiagnosed Diseases Program, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, USA. · Pubmed 28655310
  • Blizard Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom. · Blizard Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom. Electronic address: · Pubmed 28619431
  • Neurology Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel, University of Basel, Basel, Switzerland. · Department of Neurology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. · Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Center for Neurological Disorders and The Regional Multiple Sclerosis Center, Wheaton Franciscan Health Care, Milwaukee, WI, USA. · Judith Jaffe Multiple Sclerosis Center, Weill Cornell Medical College, New York, NY, USA. · AbbVie, North Chicago, IL, USA. · Biogen, Cambridge, MA, USA. · Biogen, Zug, Switzerland. · Pubmed 28080250
  • Neuroimmunology Unit, Blizard Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London, UK. · Pubmed 27925187
2016
  • Queen Mary University London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK. Electronic address: · Pubmed 27640923
  • Queen Mary University London, Barts and The London School of Medicine and Dentistry, Blizard Institute, 4 Newark Street, London E1 2AT, United Kingdom. Electronic address: · Pubmed 27456893
  • Queen Mary University London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK. Electronic address: · Melbourne Brain Centre, Royal Melbourne Hospital, University of Melbourne, Parkville, Australia. Electronic address: · Department of Neurology, RUTGERS-Robert Wood Johnson Medical School, New Brunswick, NJ, USA. Electronic address: · Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK. Electronic address: · European Health Economics, Mulhouse, France. Electronic address: · Shift.ms, Leeds, UK. Electronic address: · Biostatistics Unit, University of Genoa, Genoa, Italy. Electronic address: · Patient Advocate in Multiple Sclerosis, Brussels, Belgium. Electronic address: · Department of Medicine, University of British Columbia, Vancouver, BC, Canada. Electronic address: · Department of Neurology, University of Colorado Denver, Aurora, CO, USA. Electronic address: · Pubmed 27640924
  • REVAL Rehabilitation Research Centre, BIOMED Biomedical Research Institute, Faculty of Medicine and Life Sciences, University of Hasselt, Diepenbeek, Belgium · Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University London, London, UK. · Ismar Healthcare, Lier, Belgium. · Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy/IRCCS Neuromed, Pozzilli, Italy. · National Multiple Sclerosis Centre, Melsbroek, Belgium. · Glostrup University Hospital, Glostrup, Denmark. · Pubmed 27465614
  • MS Center Dresden, Center of Clinical Neuroscience, Neurological Clinic, University Hospital Carl Gustav Carus, Dresden University of Technology, Fetscherstrasse 74, 01307, Dresden, Germany. · MS Center Dresden, Center of Clinical Neuroscience, Neurological Clinic, University Hospital Carl Gustav Carus, Dresden University of Technology, Fetscherstrasse 74, 01307, Dresden, Germany. · Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy. · Queen Mary University London, Barts and The London School of Medicine and Dentistry, London, UK. · Neurology-Neuroimmunology Department, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron University Hospital, Barcelona, Spain. · Novartis Pharma AG, Basel, Switzerland. · University of Colorado Health Sciences Center, Aurora, CO, USA. · Department of Neurology, Neuroimmunology and Multiple Sclerosis Research, University Hospital Zurich, University of Zurich, Zurich, Switzerland. · Pubmed 26705122
  • Queen Mary University of London, Blizard Institute, Barts and the London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, UK. Electronic address: · Neurology, Departments of Medicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland. Electronic address: · Department of Neurology, St. Josef-Hospital/Ruhr-University Bochum, Gudrunstraße 56, 44791 Bochum, Germany. Electronic address: · Center for Neurological Disorders and The Regional Multiple Sclerosis Center, Wheaton Franciscan Health Care St. Francis Hospital, 3237S 16th Street, Milwaukee, WI 53215, USA. Electronic address: · Department of Neurology, Medical University of Lodz, ul. Kopcinskiego 22, 90-153 Lodz, Poland. Electronic address: · Biogen, 225 Binney Street, Cambridge, MA 02142, USA. Electronic address: · AbbVie Inc., 1 North Waukegan Road, North Chicago, IL 60064, USA. Electronic address: · Biogen, 225 Binney Street, Cambridge, MA 02142, USA. Electronic address: · Biogen, 225 Binney Street, Cambridge, MA 02142, USA. Electronic address: · Biogen, 225 Binney Street, Cambridge, MA 02142, USA. Electronic address: · Pubmed 27645341
  • Department of Neurology, St. Josef-Hospital/Ruhr-University Bochum, Bochum, Germany. · Medical Image Analysis Center, University Hospital Basel, Basel, Switzerland. · Queen Mary University of London, Blizard Institute, London School of Medicine and Dentistry, London, UK. · Medical University of Lodz, Lodz, Poland. · First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. · Rush University Medical Center, Chicago, IL, USA. · DKD Helios Klinik Wiesbaden, Wiesbaden, Germany. · Hospital Vall d'Hebron University, Barcelona, Spain. · Providence Multiple Sclerosis Center, Portland, OR, USA. · Biogen, Cambridge, MA, USA. · AbbVie Biotherapeutics Inc., Redwood, CA, USA. · Pubmed 27461166
  • Neuroimmunology Unit, Blizard Institute, Barts and the London, Queen Mary University of London, UK. Electronic address: · Neuroimmunology Unit, Blizard Institute, Barts and the London, Queen Mary University of London, UK. · College of Medicine, Swansea University, Swansea, Wales, UK. · North American Research Committee on Multiple Sclerosis (NARCOMS), The University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 27919479
  • Queen Mary University London; Blizard Institute, Barts and the London School of Medicine and Dentistry, London, United Kingdom. · Royal London Hospital, Barts Health NHS Trust, London, United Kingdom. · NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London (UCL) Institute of Neurology, London, United Kingdom. · National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, United Kingdom. · Pubmed 27802296
  • Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, England. · The Townsville Hospital, Queensland, Australia. · University of Nottingham, Nottingham, England. · Barts and The London School of Medicine and Dentistry, London, England. · South Eastern Health and Social Care Trust, Belfast, Northern Ireland. · Belfast Trust, Belfast, Northern Ireland. · Imperial College London, London, England. · Cardiff University, Cardiff, Wales. · University of St Andrews, St Andrews, Scotland. · Pubmed 27366989
  • Blizard Institute, Queen Mary University of London, London, UK · Pubmed 27279588
  • Queen Mary University London, Blizard Institute, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, UK. Electronic address: · Pubmed 27237749
  • Department of Neurosciences, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. · Pubmed 27114560
  • Unit of Health-Care Epidemiology, Nuffield Department of Population Health, University of Oxford, Oxford, UK. · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary, University of London, London, UK; Department of Neurology, Barts Health NHS Trust, The Royal London Hospital, London, UK. · Unit of Health-Care Epidemiology, Nuffield Department of Population Health, University of Oxford, Oxford, UK · Pubmed 26857201
  • Department of Neurology and Medical Image Analysis Center, MIAC, University Hospital Basel, Basel, Switzerland. · DKD Helios Klinik Wiesbaden, Wiesbaden, Germany. · Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA. · Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany. · Department of Neurology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. · Department of Neurology, Medical University of Lodz, Lodz, Poland. · Department of Neurology, Rush University Medical Center, Chicago, IL, USA. · Biogen, Cambridge, MA, USA. · Pubmed 26806217
  • Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK Neurocentre of Southern Switzerland, Ospedale Civico, Lugano, Switzerland. · Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK. · Department of Neurology and INSPE, Vita-Salute San Raffaele University, Scientific Institute San Raffaele, Milan, Italy. · Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands. · Centre of Multiple Sclerosis, City Clinical Hospital 31, St. Petersburg, Russia. · Institut de Génomique Fonctionnelle, CNRS UMR5203, INSERM U661, Université Montpellier 1, Université Montpellier 2, Montpellier, France, and Université Montpellier and Hôpital Carémeau, Nîmes, France. · Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy. · Uman Diagnostics, Umeå, Sweden. · Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, MS Center, Neurocampus Amsterdam, VU University Medical Centre Amsterdam, The Netherlands. · Department of Neurology, University Hospital Basel, Basel, Switzerland. · Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK Department of Neurology, University Hospital Basel, Basel, Switzerland. · Pubmed 25716934
  • Queen Mary University London, Blizard Institute, Barts & The London School of Medicine & Dentistry, London, UK. · Pubmed 27053013
2015
  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Department of Neuroradiology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Pubmed 26195051
  • Centre for Neuroscience and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Blizard Building, 4 Newark Street, London, E1 2AT, UK. · Centre for Neuroscience and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Blizard Building, 4 Newark Street, London, E1 2AT, UK. · Pubmed 25502545
  • From the Neuroimmunology Unit (J.K., G.D., G.G.), Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK; Neurology, Departments of Medicine, Clinical Research and Biomedicine (J.K., J.L., L.K.), and the Medical Image Analysis Center (MIAC) (E.-W.R.), University Hospital, Basel, Switzerland; Novartis Pharmaceuticals Corporation (T.S., Y.C., G.F.), East Hanover, NJ; Novartis Pharma AG (F.D.), Basel, Switzerland; and Novartis Healthcare Pvt Ltd (A.S.), Hyderabad, India. · From the Neuroimmunology Unit (J.K., G.D., G.G.), Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK; Neurology, Departments of Medicine, Clinical Research and Biomedicine (J.K., J.L., L.K.), and the Medical Image Analysis Center (MIAC) (E.-W.R.), University Hospital, Basel, Switzerland; Novartis Pharmaceuticals Corporation (T.S., Y.C., G.F.), East Hanover, NJ; Novartis Pharma AG (F.D.), Basel, Switzerland; and Novartis Healthcare Pvt Ltd (A.S.), Hyderabad, India. · Pubmed 25809304
  • Queen Mary University of London, Blizard Institute, London, United Kingdom. Electronic address: · Department of Neurology, St. Josef-Hospital, Ruhr University Bochum, Bochum, Germany. · Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, Ohio. · University Hospital Basel, Neurology, Basel, Switzerland. · Virginia Mason Multiple Sclerosis Center, Seattle, Washington. · Biogen, Cambridge, Massachusetts. · First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. · Pubmed 26526385
  • Bristol Institute of Clinical Neurosciences, Learning and Research Building, Southmead Hospital, Bristol, UK. · Department of Neurology, St George's University Hospital, London, UK. · Department of Neurology, Basingstoke Hospital, Basingstoke, UK. · Department of Neurology, National Hospital for Neurology and Neurosurgery, University College, London, UK. · Department of Neurology, Queen's Hospital, Romford, UK. · Department of Neurology, University of Cambridge, Cambridge, UK. · Department of Neurology, Barts and The London School of Medicine and Dentistry, London, UK. · Department of Neurology, Hurstwood Park Neurological Centre, Haywards Heath. · Department of Neurology, Department of Neurology, Barts and The London School of Medicine and Dentistry, London, UK. · Department of Neurology, University Hospital, Coventry, UK. · Department of Neurology, Kings' College Hospital, London, UK. · Department of Neurology, The Walton Hospital, Liverpool, UK. · Department of Neurology, University of Plymouth, Plymouth, UK. · Pubmed 26101071
  • Centre for Neuroscience and Trauma, Blizard Institute, Queen Mary, University of London, Whitechapel, London E1 2AT, UK. · Centre for Primary Care and Public Health Blizard Institute, Barts and The London School of Medicine and Dentistry, Yvonne Carter Building, 58 Turner Street, London, E1 2AB, UK. · School of 717 Health Sciences, University of Southampton, Highfield, Building 67, 718, Southampton, SO17 1BJ, UK. · Centre for Neuroscience and Trauma, Blizard Institute, Queen Mary, University of London, Whitechapel, London E1 2AT, UK. · Pubmed 25903748
  • Department of Clinical Neurosciences, Addenbrooke's Hospital, Cambridge, UK. · Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK. · Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Pubmed 25878229
  • Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, 4 Newark Street, London E1 2AT, England. · Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, 4 Newark Street, London E1 2AT, England. Electronic address: · Pubmed 25787060
  • Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, United Kingdom. Electronic address: · Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, United Kingdom. · Pubmed 25787047
  • Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK/ Departments of Neurology and Biomedicine, University Hospital Basel, University of Basel, Switzerland. · Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK. · Wolfson Institute of Preventive Medicine, Queen Mary University of London, Barts and the London School for Medicine and Dentistry, UK. · Department of Neurology and INSPE, Vita-Salute San Raffaele University, Scientific Institute San Raffaele, Italy. · Department of Neurology, Erasmus MC University Medical Center, The Netherlands. · Centre of Multiple Sclerosis, City Clinical Hospital#31, Russia. · Institut de Génomique Fonctionelle, CNRS UMR5203, INSERM U661, Université Montpellier 1, Université Montpellier, France, and Hôpital Carémeau, France. · Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Italy. · Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Sweden. · Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Receca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain. · Departments of Neurology and Clinical Chemistry, MS Center, Neurocampus Amsterdam, VU University Medical Centre Amsterdam, The Netherlands and BioMS-eu network. · Department of Neurology, Innsbruck Medical University, Austria. · Department of Radiology, Innsbruck Medical University, Austria. · Department of Health Sciences and IRCAD, Eastern Piedmont University, Italy. · Department of Neurology and Immunology, Hospital Ramón y Cajal, Spain. · Department of Neurology, Charles University in Prague, Czech Republic. · Department of Neurology, CSF Laboratory and MS Outpatient Unit, University of Ulm, Germany. · Center for Neuroimmunology and Department of Neurology. Institut d'investigacions Biomèdiques August Pi Sunyer (IDIBAPS) - Hospital Clinic of Barcelona, Spain. · Dr Orhan Öcalgiray Molecular Biology-Biotechnology and Genetics Research Centre, Istanbul Technical University, Turkey. · Department of Neurology, Istanbul University, Turkey. · Department of Neurology, Medical Faculty, Heinrich-Heine-University, Germany. · Department of Neurology, University of Szeged, Hungary. · C. Mondino National Neurological Institute, Italy. · Pôle de Neurosciences Cliniques, Service de Neurologie, Centre de Résonance Magnétique Biologique et Médicale, Centre Hospitalier Universitaire Timone, Laboratoire d'histocompatibilité, Etablissement Français du Sang Alpes Méditerrannée, Aix Marseille Université, France. · Department of Neurology, Medical University of Graz, Austria. · Department of Neurology, Université de Lyon, Université Claude Bernard-Lyon 1, France. · Clinic of Neurology, Belgrade University School of Medicine, Serbia. · Unit of Functional Imaging, Glostrup Hospital, University of Copenhagen, Denmark. · Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden. · Neurology Unit, Dept. of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Policlinico. · KG Jebsen Centre for MS-Research, Department of Clinical Medicine, Haukeland University Hospital, University of Bergen, Norway. · Department of Neurology, University of Genoa, Italy. · Centre for Experimental Neurological Therapies, S. Andrea Hospital-site, Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University, Italy. · Department of Neurology of Hospital Británico of Buenos Aires, Argentina. · Department of Neurology, Medical University of Lublin, Poland. · Department of Neurology, Glostrup Hospital, University of Copenhagen, Denmark. · Department of Neurology, University of Toulouse, France. · MS Unit, Neurology Department, La Fe University and Polytechnic Hospital, Instituto de investigación Sanitaria La Fe, Spain. · Departments of Neurology and Biomedicine, University Hospital Basel, University of Basel, Switzerland. · MS Centre, SCDU Neurology, Head and Neck Department, AOU Maggiore della Carità, Italy. · Department of Physiology, Anatomy and Genetics and Medical Research Council Functional Genomics Unit, University of Oxford, UK. · Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK · Pubmed 25680984
  • The Albion Centre, Prince of Wales Hospital, Sydney, New South Wales, Australia Centre for Neuroscience and Trauma, The Blizard Institute of Cell and Molecular Science, Queen Mary University of London, London, UK. · Unit of Health-Care Epidemiology, Nuffield Department of Population Health, University of Oxford, Oxford, UK. · Centre for Neuroscience and Trauma, The Blizard Institute of Cell and Molecular Science, Queen Mary University of London, London, UK. · Pubmed 25091370
  • St. Josef Hospital, Ruhr University, Germany · Queen Mary University of London, Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK. · Multiple Sclerosis Program, Baylor Institute for Immunology Research, Dallas, TX, USA. · Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. · Biogen Idec, Inc., Cambridge, MA, USA. · Pubmed 24990854
  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Neuroscience and Trauma, 4 Newark Street, Clapham, London E1 2AT, United Kingdom. Electronic address: · Department of Neurology, Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Neurology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland. · Unidad de EM. CSUR, Hospital Universitario Macarena, Dr Fedriani 3, 41009 Sevilla, Spain. · Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Edgbaston, Birmingham B15 2WB, United Kingdom. · Department of Neurology, Cambridge University Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge, United Kingdom. · Department of Neurology, Imperial Healthcare NHS Trust, Charing Cross Hospital, United Kingdom. · Institute of Neurological Sciences, Southern General Hospital, Glasgow G51 4TF, United Kingdom. · Center of Clinical Neuroscience, Department of Neurology, Neurological University Clinic Dresden, University Clinic Carl Gustav Carus Dresden, University of Technology Dresden, Fetscherstr, 74, 01307 Dresden, Germany. · Department of Laboratory Medicine, Stem Cell Center, Lund University, Sweden; Department of Hematology, Skåne University Hospital, Sweden. · Pubmed 25787058
2014
  • From the Queen Mary University of London (G.G.), Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK; and the Department of Neurology (R.T.N.), Washington University School of Medicine, St. Louis, MO. · Pubmed 24610331
  • Centre for Neuroscience and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK. Electronic address: · Pubmed 24507540
  • Icahn School of Medicine at Mount Sinai, The Corinne Goldsmith Dickinson Center for MS, 5 E. 98th Street, Box 113B, New York, NY, USA. Electronic address: · University of Alabama at Birmingham, AL, USA. Electronic address: · Barts and the London School of Medicine and Dentistry, London, United Kingdom. Electronic address: · Biogen Idec Inc., Cambridge, MA, USA. Electronic address: · Biogen Idec Inc., Cambridge, MA, USA. Electronic address: · Biogen Idec Inc., Cambridge, MA, USA. Electronic address: · Pubmed 25891549
  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. Electronic address: · St Josef-Hospital, Ruhr-University Bochum, Bochum, Germany. · Medical University of Lodz, Lodz, Poland. · Charles University in Prague, Prague, Czech Republic. · Vall d'Hebron University Hospital, Barcelona, Spain. · University Hospital Basel, Basel, Switzerland. · Rush University Medical Center, Chicago, IL, USA. · Biogen Idec, Cambridge, MA, USA. · Pubmed 24656609
  • Neuroscience Institute, Virginia Mason Medical Center, Seattle, Washington. Electronic address: · Department of Neurology, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio. · Department of Neurology, Saint Josef-Hospital/Ruhr-University Bochum, Bochum, Germany. · Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom. · Multiple Sclerosis Program, Baylor Institute for Immunology Research, Dallas, Texas. · Biogen Idec Inc, Cambridge, Massachusetts. · Departments of Neurology and Biomedicine, University Hospital Basel, Basel, Switzerland. · Pubmed 25315404
  • Oxford University Medical School, John Radcliffe Hospital, Oxford, England. · Unit of Health-Care Epidemiology, Nuffield Department of Population Health, University of Oxford, Oxford, England. · Blizard Institute, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London, England. · Pubmed 25200540
  • Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom. · Oxford medical school, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom. · Pubmed 24794218
  • Neuroimmunology Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK Department of Pathology, VU University Medical Center and MS Center, Amsterdam, The Netherlands. · Department of Pathology, VU University Medical Center and MS Center, Amsterdam, The Netherlands. · Neuroimmunology Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK MS Unit, Neurology Department, La Fe University Hospital, Valencia, Spain. · Neuroimmunology Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK. · Neuroimmunology Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK · Pubmed 24515731
  • Department of Medical Genetics, University of British Columbia (BC), Vancouver, Canada. · Wellcome Trust Centre for Human Genetics, University of Oxford, UK Nuffield Department of Clinical Neurosciences, University of Oxford, UK. · Department of Medical Genetics, University of Ottawa, Canada. · Department of Nutritional Sciences, University of Toronto, Canada Neurosciences and Mental Health Research Institute, The Hospital for Sick Children, University of Toronto, Canada. · Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Department of Neurology, Fraser Health Multiple Sclerosis Clinic, Burnaby, Canada. · Department of Medical Genetics, University of British Columbia (BC), Vancouver, Canada Division of Neurology, University of BC, Vancouver, Canada · Pubmed 24414537
  • Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London, E1 2AT, UK, · Pubmed 24375015
  • Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London E1 2AT, UK. Electronic address: · Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London E1 2AT, UK. · Pubmed 25220965
2012
  • Centre for Neuroscience and Trauma, Barts and the London School of Medicine and Dentistry, London, UK. · Pubmed 22398661
  • Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Pubmed 22249762
  • Oxford Outcomes, Seacourt Tower, West Way, Botley, Oxford, OX2 0JJ, UK. · Oxford Outcomes, Seacourt Tower, West Way, Botley, Oxford, OX2 0JJ, UK. · University of Medicine and Dentistry, New Jersey Medical School, Newark, NJ, USA. · Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK. · Department of Neurology and Institute of Experimental Neurology, Università Vita-Salute San Raffaele, Milan, Italy. · Multiple Sclerosis Center, Department of Neurology, University of Miami, FL, USA. · Bamberg Hospital and University of Erlangen, Bamberg, Germany. · Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · University of Lille - Nord de France, Lille, France. · Merck Serono S.A., Geneva, Switzerland. · Pubmed 27933596
  • Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London E1 2AT, UK. · Pubmed 22146410
2011
  • Neuroscience and Trauma Centre, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AN, UK. · Pubmed 21439452
  • Gavin Giovannoni Neuroscience and Trauma Centre, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, UK, Tel: +44 20 7377 7472, Fax: +44 20 7377 7300, E-mail: · Pubmed 21689495
  • Queen Mary University London, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, London, UK. · Pubmed 21397565
2010
  • Queen Mary University of London, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, London, UK. · Pubmed 20203146
  • Queen Mary University London, the Blizard Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, London, United Kingdom. · Pubmed 20089960
2009
  • Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, London, UK. · Pubmed 18755819
2017
  • From Hospital Vall d'Hebron University, Barcelona (X.M.); University of California, San Francisco, San Francisco (S.L.H.), and Genentech, South San Francisco (D.M., H.G., P.C.) - both in California; University Hospital Basel, University of Basel (L.K.), and F. Hoffmann-La Roche (A.S., P.F., S.B., N.M.), Basel, Switzerland; McGill University (D.L.A., A.B.-O.) and NeuroRx Research (D.L.A.), Montreal, and University of British Columbia, Vancouver (A.T.) - both in Canada; University Vita-Salute San Raffaele, Milan (G.C.); University Hospital of Strasbourg, Clinical Investigation Center (INSERM Unité 1434), Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France (J.S.); Barts and the London School of Medicine and Dentistry, London (G.G.); Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf (H.-P.H.), and Technical University of Munich and Munich Cluster for Systems Neurology, Munich (B.H.) - both in Germany; Icahn School of Medicine at Mount Sinai, New York (F.L.); University of Miami, Miami (K.W.R.); Medical University of Łódź, Łódź, Poland (K.S.); and McGovern Medical School, University of Texas Health Science Center at Houston, Houston (J.S.W.). · Pubmed 28002688
  • From the University of California, San Francisco (S.L.H.), and Genentech, South San Francisco (D.M., P.C., H.G.) - both in California; McGill University (A.B.-O., D.L.A.) and NeuroRx Research (D.L.A.), Montreal, and University of British Columbia, Vancouver, BC (A.T.) - both in Canada; University Vita-Salute San Raffaele, Milan (G.C.); Barts and the London School of Medicine and Dentistry, London (G.G.); Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf (H.-P.H.), and the Technical University of Munich and Munich Cluster for Systems Neurology, Munich (B.H.) - both in Germany; Icahn School of Medicine at Mount Sinai, New York (F.L.); Hospital Vall d'Hebron University, Barcelona (X.M.); University of Miami, Miami (K.W.R.); Medical University of Lodz and Center for Neurology, Lodz, Poland (K.S.); McGovern Medical School, University of Texas Health Science Center at Houston, Houston (J.S.W.); and F. Hoffmann-La Roche (G.K., P.F., S.B., N.M.) and University Hospital Basel, University of Basel (L.K.), Basel, Switzerland. · Pubmed 28002679
  • From the Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General Hospital in Prague, Czech Republic; Neuroimmunology and Multiple Sclerosis Research, Department of Neurology (S.S.), University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Sanofi (D.H.M., K.T., M.C.C., D.J., M.A.P.), Cambridge, MA; Envision Scientific Solutions (P.X.), Philadelphia, PA; Envision Scientific Solutions (R.J.H.), Sydney, NSW, Australia; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · From the Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General Hospital in Prague, Czech Republic; Neuroimmunology and Multiple Sclerosis Research, Department of Neurology (S.S.), University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Sanofi (D.H.M., K.T., M.C.C., D.J., M.A.P.), Cambridge, MA; Envision Scientific Solutions (P.X.), Philadelphia, PA; Envision Scientific Solutions (R.J.H.), Sydney, NSW, Australia; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · Pubmed 28835403
  • From the Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Neuroimmunology and Multiple Sclerosis Research (S.S.), Department of Neurology, University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Department of Clinical Neurosciences (D.A.S.C., A.J.C.), University of Cambridge, UK; Sanofi (D.H.M., K.T., C.E.R., D.J., M.A.P.), Cambridge, MA; Evidence Scientific Solutions (R.J.H.), Sydney, NSW, Australia; and Evidence Scientific Solutions (P.X.), Philadelphia, PA. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · From the Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Neuroimmunology and Multiple Sclerosis Research (S.S.), Department of Neurology, University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Department of Clinical Neurosciences (D.A.S.C., A.J.C.), University of Cambridge, UK; Sanofi (D.H.M., K.T., C.E.R., D.J., M.A.P.), Cambridge, MA; Evidence Scientific Solutions (R.J.H.), Sydney, NSW, Australia; and Evidence Scientific Solutions (P.X.), Philadelphia, PA. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · Pubmed 28835401
  • From Neurologic Clinic and Policlinic (J.K., C.B., O.Y.), Departments of Medicine, Clinical Research, and Biomedicine, University Hospital Basel, University of Basel, Switzerland; Department of Neurology (B.N., E.W.), University of California San Francisco; Department of Neuroimmunology (D.G.), Queen Square, Institute of Neurology, London; independent statistician (S.M.), Haddenham, Bucks, UK; Department of Neurology (D.P.), University of Southern California, Los Angeles; and Department of Neuroscience and Trauma (G.G., S.G.), Queen Mary University of London, UK. · From Neurologic Clinic and Policlinic (J.K., C.B., O.Y.), Departments of Medicine, Clinical Research, and Biomedicine, University Hospital Basel, University of Basel, Switzerland; Department of Neurology (B.N., E.W.), University of California San Francisco; Department of Neuroimmunology (D.G.), Queen Square, Institute of Neurology, London; independent statistician (S.M.), Haddenham, Bucks, UK; Department of Neurology (D.P.), University of Southern California, Los Angeles; and Department of Neuroscience and Trauma (G.G., S.G.), Queen Mary University of London, UK. · Pubmed 28148632
2016
  • From Partners Pediatric MS Center (T.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Divisione di Neurologia 2-Centro Studi Sclerosi Multipla (A.G.), Ospedale di Gallarate, Italy; Department of Neurology (B.B.-K.), Medical University of Vienna, Austria; Department of Neurology, Neurosurgery and Medical Genetics (A.B.), Pirogov's Russian National Research Medical University, Moscow; Barts and The London School of Medicine and Dentistry (G.G.), London, UK; and Department of Neurology (D.P.), Children's Hospital of Eastern Ontario, University of Ottawa, Canada. · From Partners Pediatric MS Center (T.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Divisione di Neurologia 2-Centro Studi Sclerosi Multipla (A.G.), Ospedale di Gallarate, Italy; Department of Neurology (B.B.-K.), Medical University of Vienna, Austria; Department of Neurology, Neurosurgery and Medical Genetics (A.B.), Pirogov's Russian National Research Medical University, Moscow; Barts and The London School of Medicine and Dentistry (G.G.), London, UK; and Department of Neurology (D.P.), Children's Hospital of Eastern Ontario, University of Ottawa, Canada. · Pubmed 27572854
  • From Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Sanofi Genzyme (D.H.M., S.L.L., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (S.M.K.), Philadelphia, PA (at the time the work was conducted). · From Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Sanofi Genzyme (D.H.M., S.L.L., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (S.M.K.), Philadelphia, PA (at the time the work was conducted). · Pubmed 27733571
  • From NeuroRx Research (D.L.A.) and Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Department of Biomedical Engineering (E.F.) and Mellen Center (J.A.C.), Cleveland Clinic, OH; Zagreb Medical School and University Hospital Center (V.V.B.), Croatia; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Clinical Centre Kragujevac (M.S.), Clinic of Neurology, Serbia; Brigham and Women's Hospital Center for Neurologic Diseases (H.L.W.), Boston, MA; Sanofi Genzyme (S.L.L., D.H.M., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (D.R.T.), Horsham, West Sussex, UK. Dr. Panzara is currently with Wave Life Sciences, Cambridge, MA. · From NeuroRx Research (D.L.A.) and Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Department of Biomedical Engineering (E.F.) and Mellen Center (J.A.C.), Cleveland Clinic, OH; Zagreb Medical School and University Hospital Center (V.V.B.), Croatia; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Clinical Centre Kragujevac (M.S.), Clinic of Neurology, Serbia; Brigham and Women's Hospital Center for Neurologic Diseases (H.L.W.), Boston, MA; Sanofi Genzyme (S.L.L., D.H.M., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (D.R.T.), Horsham, West Sussex, UK. Dr. Panzara is currently with Wave Life Sciences, Cambridge, MA. · Pubmed 27590291
2015
  • From Neurology, the Departments of Medicine, Clinical Research and Biomedicine (L.K., T.D., Y.N., T.S.), the Medical Image Analysis Center (MIAC) (E.-W.R., T.S., N.M.-L.), and the Department of Radiology, Division of Neuroradiology (T.S.), University Hospital, University of Basel, Switzerland; the Department of Neuroscience (G.C.), Scientific Institute H. San Raffaele, University of Milan, Italy; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Royal Melbourne Hospital (H.B.), Parkville, Australia; the Department of Neurology (H.W.), University of Münster, Germany; the Neuroscience and Trauma Centre (G.G.), Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK; the Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Oxford PharmaGenesis Ltd. (S.G.), Tubney Warren Barns, Oxford, UK; Novartis Pharma AG (P.v.R., Y.Z., F.D., D.T.), Basel, Switzerland; and Novartis Pharmaceutical Corporation (R.G.), East Hanover, NJ. · From Neurology, the Departments of Medicine, Clinical Research and Biomedicine (L.K., T.D., Y.N., T.S.), the Medical Image Analysis Center (MIAC) (E.-W.R., T.S., N.M.-L.), and the Department of Radiology, Division of Neuroradiology (T.S.), University Hospital, University of Basel, Switzerland; the Department of Neuroscience (G.C.), Scientific Institute H. San Raffaele, University of Milan, Italy; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Royal Melbourne Hospital (H.B.), Parkville, Australia; the Department of Neurology (H.W.), University of Münster, Germany; the Neuroscience and Trauma Centre (G.G.), Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK; the Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Oxford PharmaGenesis Ltd. (S.G.), Tubney Warren Barns, Oxford, UK; Novartis Pharma AG (P.v.R., Y.Z., F.D., D.T.), Basel, Switzerland; and Novartis Pharmaceutical Corporation (R.G.), East Hanover, NJ. · Pubmed 26024899
  • Neuroimmunology Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London, E1 2AT, UK, · Pubmed 25537576
2014
  • From the Queen Mary University London (R.D., K.S., G.G.), Blizard Institute, UK; Neurological Institute (R.A.R.), Mellen Center for MS Treatment and Research, Cleveland, OH; and Royal London Hospital (R.D., B.T., K.S., G.G.), Barts Health NHS Trust, UK. · Pubmed 24336144
  • 1 Neuroimmunology Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Pubmed 24287115
  • Department of Neuroscience and Trauma, Blizard Institute, Queen Mary University of London, UK. · Pubmed 24192216
  • 1Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark St., London E1 2AT, UK. · Pubmed 24121462
2013
  • Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, London, UK. · Pubmed 23698130
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University, London, UK. · Pubmed 23468558
  • Blizard Institute, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, UK. · Pubmed 23431079
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London, E1 2AT, UK. · Pubmed 23315260
  • Queen Mary University of London, Blizard Institute, Newark Street, London E1 2AT. · Pubmed 23152637
  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom. · Pubmed 24223903
  • Neuroimmunology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom. · Pubmed 24130809
  • Barts and the London School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, 4 Newark Street, London, E1 2AT, UK. · Pubmed 23807152
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Department of Neurology, University Hospital Basel, Basel, Switzerland. · Pubmed 23763388
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK. · Pubmed 23529999
  • Blizard Institute and the London School of Medicine and Dentistry, London, UK. · Pubmed 23465040
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University, London, UK. · Pubmed 23154877
2012
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University, UK. · Pubmed 22740489
  • Queen Mary University of London, Blizard Institute, Barts & The London School of Medicine and Dentistry, London, UK. · Pubmed 22583439
  • Department of Neuroinflammation, UCL Institute of Neurology, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London E1 2AT, UK. · Pubmed 22258390
  • Neuroimmunology Group, Centre for Neuroscience and Trauma, Blizard Institute of Cell and Molecular Science, Queen Mary University London, Barts and The London School of Medicine and Dentistry, London, UK. · Pubmed 22132878
  • Blizard Institute, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London, UK. · Pubmed 21993498
2011
  • Centre for Neuroscience and Trauma, Blizard Institute of Cell and Molecular Science, London E1 2AT, UK. · Pubmed 22019113
  • Centre for Neuroscience and Trauma, Blizard Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom. · Pubmed 21729281
  • Blizard Institute of Cell and Molecular Science, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, England, UK. · Pubmed 21482926
2010
  • Blizard Institute of Cell and Molecular Science, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, London, UK. · Pubmed 20610348
  • Queen Mary University of London, Neuroscience & Trauma Centre, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, London, UK. · Pubmed 20194583
  • Neuroimmunology Unit, Queen Mary University of London, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, 4 Newark Street, Whitechapel, London E1 2AT, United Kingdom. · Pubmed 20171744
Probable:    Miscellaneous institutions in London, EN      
2018
  • Department of Neurology, St George's Hospital NHS Trust, London, UK. · Centre for Clinical Neurosciences, St George's University, London, UK. · Department of Neurology, King's College Hospital NHS Trust, London, UK. · Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. · Blizard Institute, Queen Mary University, London, UK. · Pubmed 28947637
  • Medical Park Loipl, Bischofswiesen, Germany. Electronic address: · Università di Roma Tor Vergata, Rome & IRCCS Neuromed, Pozzilli, IS, Italy. · Tampere University Hospital, Tampere, Finland. · Blizard Institute, Bart's School of Medicine and Dentistry, London, UK. · Dept of Neurology and Center for Clinical Neuroscience, First Medical Faculty, Charles University, Prague, Czech Republic. · Kliniken Valens, Valens, Switzerland. · European Health Economics, Spéracèdes, France. · Royal Holloway, University of London, Egham, UK. · Western University, London, Ontario, Canada. · University Hospital San Carlos, Madrid, Spain. · Universitätsspital Zürich, Zurich, Switzerland. · European Multiple Sclerosis Platform, Brussels, Belgium. · Northern Ireland Neurology Service, Portadown, UK. · University of Lille, Lille, France. · MS Society UK, London, UK. · National MS Society, New York, USA. · Asociación Discapacidad Sin Distancia, Gexto, Spain. · Civic Association SMS, Prague, Czech Republic. · Association Française des Sclérosés en Plaques, Blagnac, France. · Shift MS, Leeds, UK. · Latvian MS Association, Riga, Latvia. · National MS Society, NC, USA. · Merck KGaA, Darmstadt, Germany. · Pubmed 29241142
2016
  • Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK. · Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK Division of Neuroscience, University of Manchester, Manchester, UK. · Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK University of Genoa, Genoa, Liguria, Italy. · Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy. · Queen Mary College London, London, UK. · Pubmed 27009310
  • Blizard Institute, Queen Mary University, 4 Newark Street, London E1 2AT, England. · Blizard Institute, Queen Mary University, 4 Newark Street, London E1 2AT, England. Electronic address: · First Pavlov State Medical University, Center for Molecular Medicine, Laboratory of Autoimmune Diagnostics, 6/8 Leo Tolstoy St, 197022 Saint Petersburg, Russia. · Federal Almazov Medical Research Centre, Saint Petersburg, Russia. · F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Grenzacherstrasse, Basel, Switzerland. · MS Center (City Clinical Hospital 31), Saint Petersburg, Russia. · Pubmed 27063622
2015
  • Sozialstiftung Bamberg Hospital, Bamberg, Germany. Electronic address: · Moscow MS Centre, Russian State Research Medical University named by NI Pirogov, Moscow, Russia. · Università di Roma Tor Vergata, Rome, Italy. · Tampere University Hospital, Tampere, Finland. · Blizard Institute, Bart׳s School of Medicine and Dentistry, London, UK. · General Faculty Hospital, Charles University, Prague, Czech Republic. · European Charcot Foundation, Molenhoek, The Netherlands. · Kliniken Valens, Valens, Switzerland. · European Health Economics, Spéracèdes, France. · Royal Holloway, University of London, Egham, UK. · CHUM Research Centre, Montreal, Quebec, Canada. · Western University, London, Ontario, Canada. · University Hospital San Carlos, Madrid, Spain. · Universitätsspital Zürich, Zürich, Switzerland. · Rehabilitation in MS (RIMS), Brussels, Belgium. · Northern Ireland Neurology Service, Portadown, UK. · University Hospital of Lille, Lille, France. · Pubmed 26008937
Probable:    University College London      
2017
  • Centre for Neuroscience and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK/Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. · Novartis Pharma AG, Basel, Switzerland. · Oxford PharmaGenesis, Oxford, UK. · Department of Neurology and Center of Clinical Neuroscience, Charles University, Prague, Czech Republic/First Faculty of Medicine, Charles University, Prague, Czech Republic/General University Hospital, Prague, Czech Republic. · Pubmed 28381105
2016
  • Department of Neurosciences, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. · Pubmed 27114560
  • Unit of Health-Care Epidemiology, Nuffield Department of Population Health, University of Oxford, Oxford, UK. · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary, University of London, London, UK; Department of Neurology, Barts Health NHS Trust, The Royal London Hospital, London, UK. · Unit of Health-Care Epidemiology, Nuffield Department of Population Health, University of Oxford, Oxford, UK · Pubmed 26857201
2015
  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Department of Neuroradiology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Pubmed 26195051
  • From the Neuroimmunology Unit (J.K., G.D., G.G.), Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK; Neurology, Departments of Medicine, Clinical Research and Biomedicine (J.K., J.L., L.K.), and the Medical Image Analysis Center (MIAC) (E.-W.R.), University Hospital, Basel, Switzerland; Novartis Pharmaceuticals Corporation (T.S., Y.C., G.F.), East Hanover, NJ; Novartis Pharma AG (F.D.), Basel, Switzerland; and Novartis Healthcare Pvt Ltd (A.S.), Hyderabad, India. · From the Neuroimmunology Unit (J.K., G.D., G.G.), Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK; Neurology, Departments of Medicine, Clinical Research and Biomedicine (J.K., J.L., L.K.), and the Medical Image Analysis Center (MIAC) (E.-W.R.), University Hospital, Basel, Switzerland; Novartis Pharmaceuticals Corporation (T.S., Y.C., G.F.), East Hanover, NJ; Novartis Pharma AG (F.D.), Basel, Switzerland; and Novartis Healthcare Pvt Ltd (A.S.), Hyderabad, India. · Pubmed 25809304
2014
  • From the Queen Mary University of London (G.G.), Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK; and the Department of Neurology (R.T.N.), Washington University School of Medicine, St. Louis, MO. · Pubmed 24610331
2017
  • From the Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General Hospital in Prague, Czech Republic; Neuroimmunology and Multiple Sclerosis Research, Department of Neurology (S.S.), University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Sanofi (D.H.M., K.T., M.C.C., D.J., M.A.P.), Cambridge, MA; Envision Scientific Solutions (P.X.), Philadelphia, PA; Envision Scientific Solutions (R.J.H.), Sydney, NSW, Australia; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · From the Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General Hospital in Prague, Czech Republic; Neuroimmunology and Multiple Sclerosis Research, Department of Neurology (S.S.), University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Sanofi (D.H.M., K.T., M.C.C., D.J., M.A.P.), Cambridge, MA; Envision Scientific Solutions (P.X.), Philadelphia, PA; Envision Scientific Solutions (R.J.H.), Sydney, NSW, Australia; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · Pubmed 28835403
  • From the Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Neuroimmunology and Multiple Sclerosis Research (S.S.), Department of Neurology, University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Department of Clinical Neurosciences (D.A.S.C., A.J.C.), University of Cambridge, UK; Sanofi (D.H.M., K.T., C.E.R., D.J., M.A.P.), Cambridge, MA; Evidence Scientific Solutions (R.J.H.), Sydney, NSW, Australia; and Evidence Scientific Solutions (P.X.), Philadelphia, PA. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · From the Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Neuroimmunology and Multiple Sclerosis Research (S.S.), Department of Neurology, University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Department of Clinical Neurosciences (D.A.S.C., A.J.C.), University of Cambridge, UK; Sanofi (D.H.M., K.T., C.E.R., D.J., M.A.P.), Cambridge, MA; Evidence Scientific Solutions (R.J.H.), Sydney, NSW, Australia; and Evidence Scientific Solutions (P.X.), Philadelphia, PA. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · Pubmed 28835401
  • From Neurologic Clinic and Policlinic (J.K., C.B., O.Y.), Departments of Medicine, Clinical Research, and Biomedicine, University Hospital Basel, University of Basel, Switzerland; Department of Neurology (B.N., E.W.), University of California San Francisco; Department of Neuroimmunology (D.G.), Queen Square, Institute of Neurology, London; independent statistician (S.M.), Haddenham, Bucks, UK; Department of Neurology (D.P.), University of Southern California, Los Angeles; and Department of Neuroscience and Trauma (G.G., S.G.), Queen Mary University of London, UK. · From Neurologic Clinic and Policlinic (J.K., C.B., O.Y.), Departments of Medicine, Clinical Research, and Biomedicine, University Hospital Basel, University of Basel, Switzerland; Department of Neurology (B.N., E.W.), University of California San Francisco; Department of Neuroimmunology (D.G.), Queen Square, Institute of Neurology, London; independent statistician (S.M.), Haddenham, Bucks, UK; Department of Neurology (D.P.), University of Southern California, Los Angeles; and Department of Neuroscience and Trauma (G.G., S.G.), Queen Mary University of London, UK. · Pubmed 28148632
2016
  • From NeuroRx Research (D.L.A.) and Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Department of Biomedical Engineering (E.F.) and Mellen Center (J.A.C.), Cleveland Clinic, OH; Zagreb Medical School and University Hospital Center (V.V.B.), Croatia; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Clinical Centre Kragujevac (M.S.), Clinic of Neurology, Serbia; Brigham and Women's Hospital Center for Neurologic Diseases (H.L.W.), Boston, MA; Sanofi Genzyme (S.L.L., D.H.M., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (D.R.T.), Horsham, West Sussex, UK. Dr. Panzara is currently with Wave Life Sciences, Cambridge, MA. · From NeuroRx Research (D.L.A.) and Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Department of Biomedical Engineering (E.F.) and Mellen Center (J.A.C.), Cleveland Clinic, OH; Zagreb Medical School and University Hospital Center (V.V.B.), Croatia; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Clinical Centre Kragujevac (M.S.), Clinic of Neurology, Serbia; Brigham and Women's Hospital Center for Neurologic Diseases (H.L.W.), Boston, MA; Sanofi Genzyme (S.L.L., D.H.M., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (D.R.T.), Horsham, West Sussex, UK. Dr. Panzara is currently with Wave Life Sciences, Cambridge, MA. · Pubmed 27590291
2015
  • From Neurology, the Departments of Medicine, Clinical Research and Biomedicine (L.K., T.D., Y.N., T.S.), the Medical Image Analysis Center (MIAC) (E.-W.R., T.S., N.M.-L.), and the Department of Radiology, Division of Neuroradiology (T.S.), University Hospital, University of Basel, Switzerland; the Department of Neuroscience (G.C.), Scientific Institute H. San Raffaele, University of Milan, Italy; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Royal Melbourne Hospital (H.B.), Parkville, Australia; the Department of Neurology (H.W.), University of Münster, Germany; the Neuroscience and Trauma Centre (G.G.), Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK; the Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Oxford PharmaGenesis Ltd. (S.G.), Tubney Warren Barns, Oxford, UK; Novartis Pharma AG (P.v.R., Y.Z., F.D., D.T.), Basel, Switzerland; and Novartis Pharmaceutical Corporation (R.G.), East Hanover, NJ. · From Neurology, the Departments of Medicine, Clinical Research and Biomedicine (L.K., T.D., Y.N., T.S.), the Medical Image Analysis Center (MIAC) (E.-W.R., T.S., N.M.-L.), and the Department of Radiology, Division of Neuroradiology (T.S.), University Hospital, University of Basel, Switzerland; the Department of Neuroscience (G.C.), Scientific Institute H. San Raffaele, University of Milan, Italy; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Royal Melbourne Hospital (H.B.), Parkville, Australia; the Department of Neurology (H.W.), University of Münster, Germany; the Neuroscience and Trauma Centre (G.G.), Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK; the Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Oxford PharmaGenesis Ltd. (S.G.), Tubney Warren Barns, Oxford, UK; Novartis Pharma AG (P.v.R., Y.Z., F.D., D.T.), Basel, Switzerland; and Novartis Pharmaceutical Corporation (R.G.), East Hanover, NJ. · Pubmed 26024899
2013
  • Department of Neuroinflammation, UCL Institute of Neurology, London, United Kingdom. · Pubmed 23936370
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Department of Neurology, University Hospital Basel, Basel, Switzerland. · Pubmed 23763388
  • Department of Neuroimmunology, Institute of Neurology, London, UK. · Pubmed 23495921
2012
  • Department of Neuroinflammation, UCL Institute of Neurology, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London E1 2AT, UK. · Pubmed 22258390
  • Department of Neuroimmunology, Institute of Neurology, London, UK. · Pubmed 22276904
2011
  • University College London, Institute of Neurology, London, UK. · Pubmed 21685230
2010
  • Institute of Neurology, University College London, London, United Kingdom. · Pubmed 20874249
  • Department of Neuroimmunology, UCL Institute of Neurology, Queen Square, London, United Kingdom. · Pubmed 21194151
2009
  • Department of Neuroinflammation, Institute of Neurology, UCL, Queen Square, London, UK. · Pubmed 19458321
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 220 total) written by Gavin Giovannoni about Multiple Sclerosis:

  • Vitamin D supplementation. 2018
  • Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group. 2018
  • The BRAIN test: a keyboard-tapping test to assess disability and clinical features of multiple sclerosis. 2018
  • Editors' Welcome. 2017
  • Cladribine to Treat Relapsing Forms of Multiple Sclerosis. 2017
  • Science is 1% inspiration and 99% biomarkers. 2017
  • "No evident disease activity": The use of combined assessments in the management of patients with multiple sclerosis. 2017
  • Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses. 2017
  • Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis. 2017
  • Marked neutropenia: Significant but rare in people with multiple sclerosis after alemtuzumab treatment. 2017
Show List of Full Article Records
Google Searches

Learn more about Gavin Giovannoni using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of London
Miscellaneous institutions in London, EN
University College London
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of London
2018
  • Department of Neurology, St George's Hospital NHS Trust, London, UK. · Centre for Clinical Neurosciences, St George's University, London, UK. · Department of Neurology, King's College Hospital NHS Trust, London, UK. · Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. · Blizard Institute, Queen Mary University, London, UK. · Pubmed 28947637
  • Department of Neurology, St. George's Hospital, London, UK. · Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London, UK. · Department of Neurophysiology, Kings College Hospital, London, UK. · Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London, UK. · Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, UK. · Pubmed 29204963
2017
  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK. · Pubmed 29168160
  • Department of Neuroscience and Trauma, Blizard Institute, Queen Mary University of London, London, UK. · Pubmed 28537780
  • Centre for Neuroscience and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK/Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. · Novartis Pharma AG, Basel, Switzerland. · Oxford PharmaGenesis, Oxford, UK. · Department of Neurology and Center of Clinical Neuroscience, Charles University, Prague, Czech Republic/First Faculty of Medicine, Charles University, Prague, Czech Republic/General University Hospital, Prague, Czech Republic. · Pubmed 28381105
  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. Electronic address: · Department of Biostatistics, University of Alabama at Birmingham School of Public Health, Birmingham, AL, USA. Electronic address: · Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · Biogen, Cambridge, MA, USA. Electronic address: · Biogen, Cambridge, MA, USA. Electronic address: · Teva Pharmaceuticals, Netanya, Israel. Electronic address: · Novartis Pharma AG, Basel, Switzerland. Electronic address: · Novartis Pharma AG, Basel, Switzerland. Electronic address: · University of Mississippi Medical Center, Jackson, MS, USA. Electronic address: · NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Queen Square, London, UK. Electronic address: · NMR Research Unit, Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, Queen Square, London, UK; NIHR University College Hospitals Biomedical Research Centre (BRC), UK. Electronic address: · Wolfson Institute for Biomedical Research, UCL, London, UK. Electronic address: · Merck, Aubonne, Switzerland. Electronic address: · Merck, Aubonne, Switzerland. Electronic address: · Department of Medicine, Imperial College, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. Electronic address: · Pubmed 28283111
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AT, United Kingdom. · Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AT, United Kingdom. Electronic address: · Pubmed 28161400
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom. Electronic address: · Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom. · Pubmed 29141806
  • Centre for Neuroscience and Trauma, Blizard Institute, Queen Mary University of London, England. · Emergency Care and Acute Medicine, Clinical Academic Group Neuroscience, Barts Health NHS (National Health Service) Trust, The Royal London Hospital, London, England. · Pubmed 28604916
  • Department of Neurology, First Faculty of Medicine, Charles University, Prague, Czech Republic. · Queen Mary University of London, Blizard Institute, London, UK. · St Josef Hospital, Ruhr University, Bochum, Germany. · Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. · Neurologic Clinic and Policlinic, University Hospital, Basel, Switzerland. · Multiple Sclerosis Program, Baylor Institute for Immunology Research, Dallas, TX, USA. · Biogen, Cambridge, MA, USA. · Pubmed 28328179
  • Department of Neurology, Hospital Universitario Quirónsalud, Madrid, Spain. · Virginia Mason Hospital & Seattle Medical Center, Seattle, WA, USA. · Multiple Sclerosis Center of Greater Washington, Vienna, VA, USA. · MS Center, Department of Neurology, First Faculty of Medicine, Charles University, Prague, Czech Republic. · Sanofi Genzyme, Cambridge, MA, USA. · Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Pubmed 27885061
  • Blizard Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London, London E1 2AT, UK. · Pubmed 29143582
  • Department of Neurology, University of Utah, Neurovirology Research Laboratory VASLCHCS, Imaging and Neuroscience Center, 175 North Medical Drive East, Salt Lake City, UT 84132, USA. Electronic address: · Department of Neurology, Queen Mary University London, The London School of Medicine and Dentistry, 4 Newark St, London, England, United Kingdom. Electronic address: · Department of Neurology, University of Münster, Schlossplatz 2, 48149 Münster, Germany. Electronic address: · Department of Neurology, Ruhr-University Bochum, Gudrunstr. 56, 44791 Bochum, Germany. Electronic address: · Department of Neurology, First Faculty of Medicine, Charles University in Prague, Kateřinská 30, 12821 Prague, Czech Republic. Electronic address: · Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research, Biomedicine, and Biomedical Engineering, University of Basel, Petersgraben 4, 4031 Basel, Switzerland. Electronic address: · Department of Neurology, Medical University of Łódź, Al. Kościuszki 4, 90-419 Łódź, Poland. Electronic address: · AbbVie Inc., 1400 Sheridan Rd, North Chicago, IL 60064, USA. Electronic address: · Biogen, 225 Binney St, Cambridge, MA 02142, USA. Electronic address: · AbbVie Biotherapeutics Inc., 1500 Seaport Blvd, Redwood City, CA 94063, USA. Electronic address: · AbbVie Inc., 1400 Sheridan Rd, North Chicago, IL 60064, USA. Electronic address: · Pubmed 29055471
  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK. Electronic address: · Emergency Care and Acute Medicine, Neuroscience Clinical Academic Group, Barts Health NHS Trust, London, UK. · The Agency of Design, 40 Martell Rd, London SE21 8EN, UK. · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Emergency Care and Acute Medicine, Neuroscience Clinical Academic Group, Barts Health NHS Trust, London, UK. · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK. · Pubmed 29055452
  • Department of Neurology, Instituto de Investigación Biomédica de Málaga, Hospital Regional Universitario, Málaga University, Málaga, Spain. · Blizard Institute, Queen Mary University of London, London, United Kingdom. · Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio. · St. Josef Hospital, Ruhr University Bochum, Bochum, Germany. · Multiple Sclerosis Program, Baylor Institute for Immunology Research, Dallas, Texas, USA. · Biogen, Cambridge, Massachusetts, USA. · Biogen, Cambridge, Massachusetts, USA. Electronic address: · Pubmed 28751099
  • Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, Building 10, Room CRC 3-2563, Bethesda, MD, 20892, USA. · Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, Building 10, Room CRC 3-2563, Bethesda, MD, 20892, USA. · Centre for Neuroscience and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK. · Translational Neuroscience Center, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, 20892, USA. · Undiagnosed Diseases Program, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, USA. · Pubmed 28655310
  • Blizard Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom. · Blizard Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom. Electronic address: · Pubmed 28619431
  • Neurology Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel, University of Basel, Basel, Switzerland. · Department of Neurology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. · Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Center for Neurological Disorders and The Regional Multiple Sclerosis Center, Wheaton Franciscan Health Care, Milwaukee, WI, USA. · Judith Jaffe Multiple Sclerosis Center, Weill Cornell Medical College, New York, NY, USA. · AbbVie, North Chicago, IL, USA. · Biogen, Cambridge, MA, USA. · Biogen, Zug, Switzerland. · Pubmed 28080250
  • Neuroimmunology Unit, Blizard Institute, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London, UK. · Pubmed 27925187
2016
  • Queen Mary University London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK. Electronic address: · Pubmed 27640923
  • Queen Mary University London, Barts and The London School of Medicine and Dentistry, Blizard Institute, 4 Newark Street, London E1 2AT, United Kingdom. Electronic address: · Pubmed 27456893
  • Queen Mary University London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK. Electronic address: · Melbourne Brain Centre, Royal Melbourne Hospital, University of Melbourne, Parkville, Australia. Electronic address: · Department of Neurology, RUTGERS-Robert Wood Johnson Medical School, New Brunswick, NJ, USA. Electronic address: · Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK. Electronic address: · European Health Economics, Mulhouse, France. Electronic address: · Shift.ms, Leeds, UK. Electronic address: · Biostatistics Unit, University of Genoa, Genoa, Italy. Electronic address: · Patient Advocate in Multiple Sclerosis, Brussels, Belgium. Electronic address: · Department of Medicine, University of British Columbia, Vancouver, BC, Canada. Electronic address: · Department of Neurology, University of Colorado Denver, Aurora, CO, USA. Electronic address: · Pubmed 27640924
  • REVAL Rehabilitation Research Centre, BIOMED Biomedical Research Institute, Faculty of Medicine and Life Sciences, University of Hasselt, Diepenbeek, Belgium · Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University London, London, UK. · Ismar Healthcare, Lier, Belgium. · Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy/IRCCS Neuromed, Pozzilli, Italy. · National Multiple Sclerosis Centre, Melsbroek, Belgium. · Glostrup University Hospital, Glostrup, Denmark. · Pubmed 27465614
  • MS Center Dresden, Center of Clinical Neuroscience, Neurological Clinic, University Hospital Carl Gustav Carus, Dresden University of Technology, Fetscherstrasse 74, 01307, Dresden, Germany. · MS Center Dresden, Center of Clinical Neuroscience, Neurological Clinic, University Hospital Carl Gustav Carus, Dresden University of Technology, Fetscherstrasse 74, 01307, Dresden, Germany. · Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy. · Queen Mary University London, Barts and The London School of Medicine and Dentistry, London, UK. · Neurology-Neuroimmunology Department, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron University Hospital, Barcelona, Spain. · Novartis Pharma AG, Basel, Switzerland. · University of Colorado Health Sciences Center, Aurora, CO, USA. · Department of Neurology, Neuroimmunology and Multiple Sclerosis Research, University Hospital Zurich, University of Zurich, Zurich, Switzerland. · Pubmed 26705122
  • Queen Mary University of London, Blizard Institute, Barts and the London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, UK. Electronic address: · Neurology, Departments of Medicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland. Electronic address: · Department of Neurology, St. Josef-Hospital/Ruhr-University Bochum, Gudrunstraße 56, 44791 Bochum, Germany. Electronic address: · Center for Neurological Disorders and The Regional Multiple Sclerosis Center, Wheaton Franciscan Health Care St. Francis Hospital, 3237S 16th Street, Milwaukee, WI 53215, USA. Electronic address: · Department of Neurology, Medical University of Lodz, ul. Kopcinskiego 22, 90-153 Lodz, Poland. Electronic address: · Biogen, 225 Binney Street, Cambridge, MA 02142, USA. Electronic address: · AbbVie Inc., 1 North Waukegan Road, North Chicago, IL 60064, USA. Electronic address: · Biogen, 225 Binney Street, Cambridge, MA 02142, USA. Electronic address: · Biogen, 225 Binney Street, Cambridge, MA 02142, USA. Electronic address: · Biogen, 225 Binney Street, Cambridge, MA 02142, USA. Electronic address: · Pubmed 27645341
  • Department of Neurology, St. Josef-Hospital/Ruhr-University Bochum, Bochum, Germany. · Medical Image Analysis Center, University Hospital Basel, Basel, Switzerland. · Queen Mary University of London, Blizard Institute, London School of Medicine and Dentistry, London, UK. · Medical University of Lodz, Lodz, Poland. · First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. · Rush University Medical Center, Chicago, IL, USA. · DKD Helios Klinik Wiesbaden, Wiesbaden, Germany. · Hospital Vall d'Hebron University, Barcelona, Spain. · Providence Multiple Sclerosis Center, Portland, OR, USA. · Biogen, Cambridge, MA, USA. · AbbVie Biotherapeutics Inc., Redwood, CA, USA. · Pubmed 27461166
  • Neuroimmunology Unit, Blizard Institute, Barts and the London, Queen Mary University of London, UK. Electronic address: · Neuroimmunology Unit, Blizard Institute, Barts and the London, Queen Mary University of London, UK. · College of Medicine, Swansea University, Swansea, Wales, UK. · North American Research Committee on Multiple Sclerosis (NARCOMS), The University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 27919479
  • Queen Mary University London; Blizard Institute, Barts and the London School of Medicine and Dentistry, London, United Kingdom. · Royal London Hospital, Barts Health NHS Trust, London, United Kingdom. · NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London (UCL) Institute of Neurology, London, United Kingdom. · National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, United Kingdom. · Pubmed 27802296
  • Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, England. · The Townsville Hospital, Queensland, Australia. · University of Nottingham, Nottingham, England. · Barts and The London School of Medicine and Dentistry, London, England. · South Eastern Health and Social Care Trust, Belfast, Northern Ireland. · Belfast Trust, Belfast, Northern Ireland. · Imperial College London, London, England. · Cardiff University, Cardiff, Wales. · University of St Andrews, St Andrews, Scotland. · Pubmed 27366989
  • Blizard Institute, Queen Mary University of London, London, UK · Pubmed 27279588
  • Queen Mary University London, Blizard Institute, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, UK. Electronic address: · Pubmed 27237749
  • Department of Neurosciences, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. · Pubmed 27114560
  • Unit of Health-Care Epidemiology, Nuffield Department of Population Health, University of Oxford, Oxford, UK. · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary, University of London, London, UK; Department of Neurology, Barts Health NHS Trust, The Royal London Hospital, London, UK. · Unit of Health-Care Epidemiology, Nuffield Department of Population Health, University of Oxford, Oxford, UK · Pubmed 26857201
  • Department of Neurology and Medical Image Analysis Center, MIAC, University Hospital Basel, Basel, Switzerland. · DKD Helios Klinik Wiesbaden, Wiesbaden, Germany. · Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA. · Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany. · Department of Neurology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. · Department of Neurology, Medical University of Lodz, Lodz, Poland. · Department of Neurology, Rush University Medical Center, Chicago, IL, USA. · Biogen, Cambridge, MA, USA. · Pubmed 26806217
  • Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK Neurocentre of Southern Switzerland, Ospedale Civico, Lugano, Switzerland. · Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK. · Department of Neurology and INSPE, Vita-Salute San Raffaele University, Scientific Institute San Raffaele, Milan, Italy. · Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands. · Centre of Multiple Sclerosis, City Clinical Hospital 31, St. Petersburg, Russia. · Institut de Génomique Fonctionnelle, CNRS UMR5203, INSERM U661, Université Montpellier 1, Université Montpellier 2, Montpellier, France, and Université Montpellier and Hôpital Carémeau, Nîmes, France. · Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy. · Uman Diagnostics, Umeå, Sweden. · Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, MS Center, Neurocampus Amsterdam, VU University Medical Centre Amsterdam, The Netherlands. · Department of Neurology, University Hospital Basel, Basel, Switzerland. · Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK Department of Neurology, University Hospital Basel, Basel, Switzerland. · Pubmed 25716934
  • Queen Mary University London, Blizard Institute, Barts & The London School of Medicine & Dentistry, London, UK. · Pubmed 27053013
2015
  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Department of Neuroradiology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Pubmed 26195051
  • Centre for Neuroscience and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Blizard Building, 4 Newark Street, London, E1 2AT, UK. · Centre for Neuroscience and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Blizard Building, 4 Newark Street, London, E1 2AT, UK. · Pubmed 25502545
  • From the Neuroimmunology Unit (J.K., G.D., G.G.), Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK; Neurology, Departments of Medicine, Clinical Research and Biomedicine (J.K., J.L., L.K.), and the Medical Image Analysis Center (MIAC) (E.-W.R.), University Hospital, Basel, Switzerland; Novartis Pharmaceuticals Corporation (T.S., Y.C., G.F.), East Hanover, NJ; Novartis Pharma AG (F.D.), Basel, Switzerland; and Novartis Healthcare Pvt Ltd (A.S.), Hyderabad, India. · From the Neuroimmunology Unit (J.K., G.D., G.G.), Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK; Neurology, Departments of Medicine, Clinical Research and Biomedicine (J.K., J.L., L.K.), and the Medical Image Analysis Center (MIAC) (E.-W.R.), University Hospital, Basel, Switzerland; Novartis Pharmaceuticals Corporation (T.S., Y.C., G.F.), East Hanover, NJ; Novartis Pharma AG (F.D.), Basel, Switzerland; and Novartis Healthcare Pvt Ltd (A.S.), Hyderabad, India. · Pubmed 25809304
  • Queen Mary University of London, Blizard Institute, London, United Kingdom. Electronic address: · Department of Neurology, St. Josef-Hospital, Ruhr University Bochum, Bochum, Germany. · Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, Ohio. · University Hospital Basel, Neurology, Basel, Switzerland. · Virginia Mason Multiple Sclerosis Center, Seattle, Washington. · Biogen, Cambridge, Massachusetts. · First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. · Pubmed 26526385
  • Bristol Institute of Clinical Neurosciences, Learning and Research Building, Southmead Hospital, Bristol, UK. · Department of Neurology, St George's University Hospital, London, UK. · Department of Neurology, Basingstoke Hospital, Basingstoke, UK. · Department of Neurology, National Hospital for Neurology and Neurosurgery, University College, London, UK. · Department of Neurology, Queen's Hospital, Romford, UK. · Department of Neurology, University of Cambridge, Cambridge, UK. · Department of Neurology, Barts and The London School of Medicine and Dentistry, London, UK. · Department of Neurology, Hurstwood Park Neurological Centre, Haywards Heath. · Department of Neurology, Department of Neurology, Barts and The London School of Medicine and Dentistry, London, UK. · Department of Neurology, University Hospital, Coventry, UK. · Department of Neurology, Kings' College Hospital, London, UK. · Department of Neurology, The Walton Hospital, Liverpool, UK. · Department of Neurology, University of Plymouth, Plymouth, UK. · Pubmed 26101071
  • Centre for Neuroscience and Trauma, Blizard Institute, Queen Mary, University of London, Whitechapel, London E1 2AT, UK. · Centre for Primary Care and Public Health Blizard Institute, Barts and The London School of Medicine and Dentistry, Yvonne Carter Building, 58 Turner Street, London, E1 2AB, UK. · School of 717 Health Sciences, University of Southampton, Highfield, Building 67, 718, Southampton, SO17 1BJ, UK. · Centre for Neuroscience and Trauma, Blizard Institute, Queen Mary, University of London, Whitechapel, London E1 2AT, UK. · Pubmed 25903748
  • Department of Clinical Neurosciences, Addenbrooke's Hospital, Cambridge, UK. · Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK. · Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · Pubmed 25878229
  • Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, 4 Newark Street, London E1 2AT, England. · Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, 4 Newark Street, London E1 2AT, England. Electronic address: · Pubmed 25787060
  • Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, United Kingdom. Electronic address: · Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, United Kingdom. · Pubmed 25787047
  • Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK/ Departments of Neurology and Biomedicine, University Hospital Basel, University of Basel, Switzerland. · Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK. · Wolfson Institute of Preventive Medicine, Queen Mary University of London, Barts and the London School for Medicine and Dentistry, UK. · Department of Neurology and INSPE, Vita-Salute San Raffaele University, Scientific Institute San Raffaele, Italy. · Department of Neurology, Erasmus MC University Medical Center, The Netherlands. · Centre of Multiple Sclerosis, City Clinical Hospital#31, Russia. · Institut de Génomique Fonctionelle, CNRS UMR5203, INSERM U661, Université Montpellier 1, Université Montpellier, France, and Hôpital Carémeau, France. · Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Italy. · Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Sweden. · Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Receca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain. · Departments of Neurology and Clinical Chemistry, MS Center, Neurocampus Amsterdam, VU University Medical Centre Amsterdam, The Netherlands and BioMS-eu network. · Department of Neurology, Innsbruck Medical University, Austria. · Department of Radiology, Innsbruck Medical University, Austria. · Department of Health Sciences and IRCAD, Eastern Piedmont University, Italy. · Department of Neurology and Immunology, Hospital Ramón y Cajal, Spain. · Department of Neurology, Charles University in Prague, Czech Republic. · Department of Neurology, CSF Laboratory and MS Outpatient Unit, University of Ulm, Germany. · Center for Neuroimmunology and Department of Neurology. Institut d'investigacions Biomèdiques August Pi Sunyer (IDIBAPS) - Hospital Clinic of Barcelona, Spain. · Dr Orhan Öcalgiray Molecular Biology-Biotechnology and Genetics Research Centre, Istanbul Technical University, Turkey. · Department of Neurology, Istanbul University, Turkey. · Department of Neurology, Medical Faculty, Heinrich-Heine-University, Germany. · Department of Neurology, University of Szeged, Hungary. · C. Mondino National Neurological Institute, Italy. · Pôle de Neurosciences Cliniques, Service de Neurologie, Centre de Résonance Magnétique Biologique et Médicale, Centre Hospitalier Universitaire Timone, Laboratoire d'histocompatibilité, Etablissement Français du Sang Alpes Méditerrannée, Aix Marseille Université, France. · Department of Neurology, Medical University of Graz, Austria. · Department of Neurology, Université de Lyon, Université Claude Bernard-Lyon 1, France. · Clinic of Neurology, Belgrade University School of Medicine, Serbia. · Unit of Functional Imaging, Glostrup Hospital, University of Copenhagen, Denmark. · Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden. · Neurology Unit, Dept. of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Policlinico. · KG Jebsen Centre for MS-Research, Department of Clinical Medicine, Haukeland University Hospital, University of Bergen, Norway. · Department of Neurology, University of Genoa, Italy. · Centre for Experimental Neurological Therapies, S. Andrea Hospital-site, Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University, Italy. · Department of Neurology of Hospital Británico of Buenos Aires, Argentina. · Department of Neurology, Medical University of Lublin, Poland. · Department of Neurology, Glostrup Hospital, University of Copenhagen, Denmark. · Department of Neurology, University of Toulouse, France. · MS Unit, Neurology Department, La Fe University and Polytechnic Hospital, Instituto de investigación Sanitaria La Fe, Spain. · Departments of Neurology and Biomedicine, University Hospital Basel, University of Basel, Switzerland. · MS Centre, SCDU Neurology, Head and Neck Department, AOU Maggiore della Carità, Italy. · Department of Physiology, Anatomy and Genetics and Medical Research Council Functional Genomics Unit, University of Oxford, UK. · Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, UK · Pubmed 25680984
  • The Albion Centre, Prince of Wales Hospital, Sydney, New South Wales, Australia Centre for Neuroscience and Trauma, The Blizard Institute of Cell and Molecular Science, Queen Mary University of London, London, UK. · Unit of Health-Care Epidemiology, Nuffield Department of Population Health, University of Oxford, Oxford, UK. · Centre for Neuroscience and Trauma, The Blizard Institute of Cell and Molecular Science, Queen Mary University of London, London, UK. · Pubmed 25091370
  • St. Josef Hospital, Ruhr University, Germany · Queen Mary University of London, Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK. · Multiple Sclerosis Program, Baylor Institute for Immunology Research, Dallas, TX, USA. · Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. · Biogen Idec, Inc., Cambridge, MA, USA. · Pubmed 24990854
  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Neuroscience and Trauma, 4 Newark Street, Clapham, London E1 2AT, United Kingdom. Electronic address: · Department of Neurology, Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Neurology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland. · Unidad de EM. CSUR, Hospital Universitario Macarena, Dr Fedriani 3, 41009 Sevilla, Spain. · Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Edgbaston, Birmingham B15 2WB, United Kingdom. · Department of Neurology, Cambridge University Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge, United Kingdom. · Department of Neurology, Imperial Healthcare NHS Trust, Charing Cross Hospital, United Kingdom. · Institute of Neurological Sciences, Southern General Hospital, Glasgow G51 4TF, United Kingdom. · Center of Clinical Neuroscience, Department of Neurology, Neurological University Clinic Dresden, University Clinic Carl Gustav Carus Dresden, University of Technology Dresden, Fetscherstr, 74, 01307 Dresden, Germany. · Department of Laboratory Medicine, Stem Cell Center, Lund University, Sweden; Department of Hematology, Skåne University Hospital, Sweden. · Pubmed 25787058
2014
  • From the Queen Mary University of London (G.G.), Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK; and the Department of Neurology (R.T.N.), Washington University School of Medicine, St. Louis, MO. · Pubmed 24610331
  • Centre for Neuroscience and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK. Electronic address: · Pubmed 24507540
  • Icahn School of Medicine at Mount Sinai, The Corinne Goldsmith Dickinson Center for MS, 5 E. 98th Street, Box 113B, New York, NY, USA. Electronic address: · University of Alabama at Birmingham, AL, USA. Electronic address: · Barts and the London School of Medicine and Dentistry, London, United Kingdom. Electronic address: · Biogen Idec Inc., Cambridge, MA, USA. Electronic address: · Biogen Idec Inc., Cambridge, MA, USA. Electronic address: · Biogen Idec Inc., Cambridge, MA, USA. Electronic address: · Pubmed 25891549
  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. Electronic address: · St Josef-Hospital, Ruhr-University Bochum, Bochum, Germany. · Medical University of Lodz, Lodz, Poland. · Charles University in Prague, Prague, Czech Republic. · Vall d'Hebron University Hospital, Barcelona, Spain. · University Hospital Basel, Basel, Switzerland. · Rush University Medical Center, Chicago, IL, USA. · Biogen Idec, Cambridge, MA, USA. · Pubmed 24656609
  • Neuroscience Institute, Virginia Mason Medical Center, Seattle, Washington. Electronic address: · Department of Neurology, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio. · Department of Neurology, Saint Josef-Hospital/Ruhr-University Bochum, Bochum, Germany. · Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom. · Multiple Sclerosis Program, Baylor Institute for Immunology Research, Dallas, Texas. · Biogen Idec Inc, Cambridge, Massachusetts. · Departments of Neurology and Biomedicine, University Hospital Basel, Basel, Switzerland. · Pubmed 25315404
  • Oxford University Medical School, John Radcliffe Hospital, Oxford, England. · Unit of Health-Care Epidemiology, Nuffield Department of Population Health, University of Oxford, Oxford, England. · Blizard Institute, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London, England. · Pubmed 25200540
  • Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom. · Oxford medical school, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom. · Pubmed 24794218
  • Neuroimmunology Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK Department of Pathology, VU University Medical Center and MS Center, Amsterdam, The Netherlands. · Department of Pathology, VU University Medical Center and MS Center, Amsterdam, The Netherlands. · Neuroimmunology Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK MS Unit, Neurology Department, La Fe University Hospital, Valencia, Spain. · Neuroimmunology Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK. · Neuroimmunology Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK · Pubmed 24515731
  • Department of Medical Genetics, University of British Columbia (BC), Vancouver, Canada. · Wellcome Trust Centre for Human Genetics, University of Oxford, UK Nuffield Department of Clinical Neurosciences, University of Oxford, UK. · Department of Medical Genetics, University of Ottawa, Canada. · Department of Nutritional Sciences, University of Toronto, Canada Neurosciences and Mental Health Research Institute, The Hospital for Sick Children, University of Toronto, Canada. · Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Department of Neurology, Fraser Health Multiple Sclerosis Clinic, Burnaby, Canada. · Department of Medical Genetics, University of British Columbia (BC), Vancouver, Canada Division of Neurology, University of BC, Vancouver, Canada · Pubmed 24414537
  • Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London, E1 2AT, UK, · Pubmed 24375015
  • Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London E1 2AT, UK. Electronic address: · Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London E1 2AT, UK. · Pubmed 25220965
2012
  • Centre for Neuroscience and Trauma, Barts and the London School of Medicine and Dentistry, London, UK. · Pubmed 22398661
  • Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Pubmed 22249762
  • Oxford Outcomes, Seacourt Tower, West Way, Botley, Oxford, OX2 0JJ, UK. · Oxford Outcomes, Seacourt Tower, West Way, Botley, Oxford, OX2 0JJ, UK. · University of Medicine and Dentistry, New Jersey Medical School, Newark, NJ, USA. · Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK. · Department of Neurology and Institute of Experimental Neurology, Università Vita-Salute San Raffaele, Milan, Italy. · Multiple Sclerosis Center, Department of Neurology, University of Miami, FL, USA. · Bamberg Hospital and University of Erlangen, Bamberg, Germany. · Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · University of Lille - Nord de France, Lille, France. · Merck Serono S.A., Geneva, Switzerland. · Pubmed 27933596
  • Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London E1 2AT, UK. · Pubmed 22146410
2011
  • Neuroscience and Trauma Centre, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London E1 2AN, UK. · Pubmed 21439452
  • Gavin Giovannoni Neuroscience and Trauma Centre, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, UK, Tel: +44 20 7377 7472, Fax: +44 20 7377 7300, E-mail: · Pubmed 21689495
  • Queen Mary University London, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, London, UK. · Pubmed 21397565
2010
  • Queen Mary University of London, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, London, UK. · Pubmed 20203146
  • Queen Mary University London, the Blizard Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, London, United Kingdom. · Pubmed 20089960
2009
  • Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, London, UK. · Pubmed 18755819
2017
  • From Hospital Vall d'Hebron University, Barcelona (X.M.); University of California, San Francisco, San Francisco (S.L.H.), and Genentech, South San Francisco (D.M., H.G., P.C.) - both in California; University Hospital Basel, University of Basel (L.K.), and F. Hoffmann-La Roche (A.S., P.F., S.B., N.M.), Basel, Switzerland; McGill University (D.L.A., A.B.-O.) and NeuroRx Research (D.L.A.), Montreal, and University of British Columbia, Vancouver (A.T.) - both in Canada; University Vita-Salute San Raffaele, Milan (G.C.); University Hospital of Strasbourg, Clinical Investigation Center (INSERM Unité 1434), Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France (J.S.); Barts and the London School of Medicine and Dentistry, London (G.G.); Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf (H.-P.H.), and Technical University of Munich and Munich Cluster for Systems Neurology, Munich (B.H.) - both in Germany; Icahn School of Medicine at Mount Sinai, New York (F.L.); University of Miami, Miami (K.W.R.); Medical University of Łódź, Łódź, Poland (K.S.); and McGovern Medical School, University of Texas Health Science Center at Houston, Houston (J.S.W.). · Pubmed 28002688
  • From the University of California, San Francisco (S.L.H.), and Genentech, South San Francisco (D.M., P.C., H.G.) - both in California; McGill University (A.B.-O., D.L.A.) and NeuroRx Research (D.L.A.), Montreal, and University of British Columbia, Vancouver, BC (A.T.) - both in Canada; University Vita-Salute San Raffaele, Milan (G.C.); Barts and the London School of Medicine and Dentistry, London (G.G.); Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf (H.-P.H.), and the Technical University of Munich and Munich Cluster for Systems Neurology, Munich (B.H.) - both in Germany; Icahn School of Medicine at Mount Sinai, New York (F.L.); Hospital Vall d'Hebron University, Barcelona (X.M.); University of Miami, Miami (K.W.R.); Medical University of Lodz and Center for Neurology, Lodz, Poland (K.S.); McGovern Medical School, University of Texas Health Science Center at Houston, Houston (J.S.W.); and F. Hoffmann-La Roche (G.K., P.F., S.B., N.M.) and University Hospital Basel, University of Basel (L.K.), Basel, Switzerland. · Pubmed 28002679
  • From the Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General Hospital in Prague, Czech Republic; Neuroimmunology and Multiple Sclerosis Research, Department of Neurology (S.S.), University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Sanofi (D.H.M., K.T., M.C.C., D.J., M.A.P.), Cambridge, MA; Envision Scientific Solutions (P.X.), Philadelphia, PA; Envision Scientific Solutions (R.J.H.), Sydney, NSW, Australia; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · From the Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General Hospital in Prague, Czech Republic; Neuroimmunology and Multiple Sclerosis Research, Department of Neurology (S.S.), University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Sanofi (D.H.M., K.T., M.C.C., D.J., M.A.P.), Cambridge, MA; Envision Scientific Solutions (P.X.), Philadelphia, PA; Envision Scientific Solutions (R.J.H.), Sydney, NSW, Australia; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · Pubmed 28835403
  • From the Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Neuroimmunology and Multiple Sclerosis Research (S.S.), Department of Neurology, University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Department of Clinical Neurosciences (D.A.S.C., A.J.C.), University of Cambridge, UK; Sanofi (D.H.M., K.T., C.E.R., D.J., M.A.P.), Cambridge, MA; Evidence Scientific Solutions (R.J.H.), Sydney, NSW, Australia; and Evidence Scientific Solutions (P.X.), Philadelphia, PA. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · From the Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Neuroimmunology and Multiple Sclerosis Research (S.S.), Department of Neurology, University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Department of Clinical Neurosciences (D.A.S.C., A.J.C.), University of Cambridge, UK; Sanofi (D.H.M., K.T., C.E.R., D.J., M.A.P.), Cambridge, MA; Evidence Scientific Solutions (R.J.H.), Sydney, NSW, Australia; and Evidence Scientific Solutions (P.X.), Philadelphia, PA. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · Pubmed 28835401
  • From Neurologic Clinic and Policlinic (J.K., C.B., O.Y.), Departments of Medicine, Clinical Research, and Biomedicine, University Hospital Basel, University of Basel, Switzerland; Department of Neurology (B.N., E.W.), University of California San Francisco; Department of Neuroimmunology (D.G.), Queen Square, Institute of Neurology, London; independent statistician (S.M.), Haddenham, Bucks, UK; Department of Neurology (D.P.), University of Southern California, Los Angeles; and Department of Neuroscience and Trauma (G.G., S.G.), Queen Mary University of London, UK. · From Neurologic Clinic and Policlinic (J.K., C.B., O.Y.), Departments of Medicine, Clinical Research, and Biomedicine, University Hospital Basel, University of Basel, Switzerland; Department of Neurology (B.N., E.W.), University of California San Francisco; Department of Neuroimmunology (D.G.), Queen Square, Institute of Neurology, London; independent statistician (S.M.), Haddenham, Bucks, UK; Department of Neurology (D.P.), University of Southern California, Los Angeles; and Department of Neuroscience and Trauma (G.G., S.G.), Queen Mary University of London, UK. · Pubmed 28148632
2016
  • From Partners Pediatric MS Center (T.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Divisione di Neurologia 2-Centro Studi Sclerosi Multipla (A.G.), Ospedale di Gallarate, Italy; Department of Neurology (B.B.-K.), Medical University of Vienna, Austria; Department of Neurology, Neurosurgery and Medical Genetics (A.B.), Pirogov's Russian National Research Medical University, Moscow; Barts and The London School of Medicine and Dentistry (G.G.), London, UK; and Department of Neurology (D.P.), Children's Hospital of Eastern Ontario, University of Ottawa, Canada. · From Partners Pediatric MS Center (T.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Divisione di Neurologia 2-Centro Studi Sclerosi Multipla (A.G.), Ospedale di Gallarate, Italy; Department of Neurology (B.B.-K.), Medical University of Vienna, Austria; Department of Neurology, Neurosurgery and Medical Genetics (A.B.), Pirogov's Russian National Research Medical University, Moscow; Barts and The London School of Medicine and Dentistry (G.G.), London, UK; and Department of Neurology (D.P.), Children's Hospital of Eastern Ontario, University of Ottawa, Canada. · Pubmed 27572854
  • From Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Sanofi Genzyme (D.H.M., S.L.L., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (S.M.K.), Philadelphia, PA (at the time the work was conducted). · From Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Sanofi Genzyme (D.H.M., S.L.L., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (S.M.K.), Philadelphia, PA (at the time the work was conducted). · Pubmed 27733571
  • From NeuroRx Research (D.L.A.) and Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Department of Biomedical Engineering (E.F.) and Mellen Center (J.A.C.), Cleveland Clinic, OH; Zagreb Medical School and University Hospital Center (V.V.B.), Croatia; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Clinical Centre Kragujevac (M.S.), Clinic of Neurology, Serbia; Brigham and Women's Hospital Center for Neurologic Diseases (H.L.W.), Boston, MA; Sanofi Genzyme (S.L.L., D.H.M., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (D.R.T.), Horsham, West Sussex, UK. Dr. Panzara is currently with Wave Life Sciences, Cambridge, MA. · From NeuroRx Research (D.L.A.) and Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Department of Biomedical Engineering (E.F.) and Mellen Center (J.A.C.), Cleveland Clinic, OH; Zagreb Medical School and University Hospital Center (V.V.B.), Croatia; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Clinical Centre Kragujevac (M.S.), Clinic of Neurology, Serbia; Brigham and Women's Hospital Center for Neurologic Diseases (H.L.W.), Boston, MA; Sanofi Genzyme (S.L.L., D.H.M., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (D.R.T.), Horsham, West Sussex, UK. Dr. Panzara is currently with Wave Life Sciences, Cambridge, MA. · Pubmed 27590291
2015
  • From Neurology, the Departments of Medicine, Clinical Research and Biomedicine (L.K., T.D., Y.N., T.S.), the Medical Image Analysis Center (MIAC) (E.-W.R., T.S., N.M.-L.), and the Department of Radiology, Division of Neuroradiology (T.S.), University Hospital, University of Basel, Switzerland; the Department of Neuroscience (G.C.), Scientific Institute H. San Raffaele, University of Milan, Italy; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Royal Melbourne Hospital (H.B.), Parkville, Australia; the Department of Neurology (H.W.), University of Münster, Germany; the Neuroscience and Trauma Centre (G.G.), Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK; the Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Oxford PharmaGenesis Ltd. (S.G.), Tubney Warren Barns, Oxford, UK; Novartis Pharma AG (P.v.R., Y.Z., F.D., D.T.), Basel, Switzerland; and Novartis Pharmaceutical Corporation (R.G.), East Hanover, NJ. · From Neurology, the Departments of Medicine, Clinical Research and Biomedicine (L.K., T.D., Y.N., T.S.), the Medical Image Analysis Center (MIAC) (E.-W.R., T.S., N.M.-L.), and the Department of Radiology, Division of Neuroradiology (T.S.), University Hospital, University of Basel, Switzerland; the Department of Neuroscience (G.C.), Scientific Institute H. San Raffaele, University of Milan, Italy; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Royal Melbourne Hospital (H.B.), Parkville, Australia; the Department of Neurology (H.W.), University of Münster, Germany; the Neuroscience and Trauma Centre (G.G.), Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK; the Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Oxford PharmaGenesis Ltd. (S.G.), Tubney Warren Barns, Oxford, UK; Novartis Pharma AG (P.v.R., Y.Z., F.D., D.T.), Basel, Switzerland; and Novartis Pharmaceutical Corporation (R.G.), East Hanover, NJ. · Pubmed 26024899
  • Neuroimmunology Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London, E1 2AT, UK, · Pubmed 25537576
2014
  • From the Queen Mary University London (R.D., K.S., G.G.), Blizard Institute, UK; Neurological Institute (R.A.R.), Mellen Center for MS Treatment and Research, Cleveland, OH; and Royal London Hospital (R.D., B.T., K.S., G.G.), Barts Health NHS Trust, UK. · Pubmed 24336144
  • 1 Neuroimmunology Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Pubmed 24287115
  • Department of Neuroscience and Trauma, Blizard Institute, Queen Mary University of London, UK. · Pubmed 24192216
  • 1Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark St., London E1 2AT, UK. · Pubmed 24121462
2013
  • Blizard Institute, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, London, UK. · Pubmed 23698130
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University, London, UK. · Pubmed 23468558
  • Blizard Institute, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, UK. · Pubmed 23431079
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London, E1 2AT, UK. · Pubmed 23315260
  • Queen Mary University of London, Blizard Institute, Newark Street, London E1 2AT. · Pubmed 23152637
  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom. · Pubmed 24223903
  • Neuroimmunology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom. · Pubmed 24130809
  • Barts and the London School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, 4 Newark Street, London, E1 2AT, UK. · Pubmed 23807152
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Department of Neurology, University Hospital Basel, Basel, Switzerland. · Pubmed 23763388
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK. · Pubmed 23529999
  • Blizard Institute and the London School of Medicine and Dentistry, London, UK. · Pubmed 23465040
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University, London, UK. · Pubmed 23154877
2012
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University, UK. · Pubmed 22740489
  • Queen Mary University of London, Blizard Institute, Barts & The London School of Medicine and Dentistry, London, UK. · Pubmed 22583439
  • Department of Neuroinflammation, UCL Institute of Neurology, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London E1 2AT, UK. · Pubmed 22258390
  • Neuroimmunology Group, Centre for Neuroscience and Trauma, Blizard Institute of Cell and Molecular Science, Queen Mary University London, Barts and The London School of Medicine and Dentistry, London, UK. · Pubmed 22132878
  • Blizard Institute, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London, UK. · Pubmed 21993498
2011
  • Centre for Neuroscience and Trauma, Blizard Institute of Cell and Molecular Science, London E1 2AT, UK. · Pubmed 22019113
  • Centre for Neuroscience and Trauma, Blizard Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom. · Pubmed 21729281
  • Blizard Institute of Cell and Molecular Science, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, England, UK. · Pubmed 21482926
2010
  • Blizard Institute of Cell and Molecular Science, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, London, UK. · Pubmed 20610348
  • Queen Mary University of London, Neuroscience & Trauma Centre, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, London, UK. · Pubmed 20194583
  • Neuroimmunology Unit, Queen Mary University of London, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, 4 Newark Street, Whitechapel, London E1 2AT, United Kingdom. · Pubmed 20171744
Miscellaneous institutions in London, EN
2018
  • Department of Neurology, St George's Hospital NHS Trust, London, UK. · Centre for Clinical Neurosciences, St George's University, London, UK. · Department of Neurology, King's College Hospital NHS Trust, London, UK. · Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. · Blizard Institute, Queen Mary University, London, UK. · Pubmed 28947637
  • Medical Park Loipl, Bischofswiesen, Germany. Electronic address: · Università di Roma Tor Vergata, Rome & IRCCS Neuromed, Pozzilli, IS, Italy. · Tampere University Hospital, Tampere, Finland. · Blizard Institute, Bart's School of Medicine and Dentistry, London, UK. · Dept of Neurology and Center for Clinical Neuroscience, First Medical Faculty, Charles University, Prague, Czech Republic. · Kliniken Valens, Valens, Switzerland. · European Health Economics, Spéracèdes, France. · Royal Holloway, University of London, Egham, UK. · Western University, London, Ontario, Canada. · University Hospital San Carlos, Madrid, Spain. · Universitätsspital Zürich, Zurich, Switzerland. · European Multiple Sclerosis Platform, Brussels, Belgium. · Northern Ireland Neurology Service, Portadown, UK. · University of Lille, Lille, France. · MS Society UK, London, UK. · National MS Society, New York, USA. · Asociación Discapacidad Sin Distancia, Gexto, Spain. · Civic Association SMS, Prague, Czech Republic. · Association Française des Sclérosés en Plaques, Blagnac, France. · Shift MS, Leeds, UK. · Latvian MS Association, Riga, Latvia. · National MS Society, NC, USA. · Merck KGaA, Darmstadt, Germany. · Pubmed 29241142
2016
  • Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK. · Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK Division of Neuroscience, University of Manchester, Manchester, UK. · Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK University of Genoa, Genoa, Liguria, Italy. · Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy. · Queen Mary College London, London, UK. · Pubmed 27009310
  • Blizard Institute, Queen Mary University, 4 Newark Street, London E1 2AT, England. · Blizard Institute, Queen Mary University, 4 Newark Street, London E1 2AT, England. Electronic address: · First Pavlov State Medical University, Center for Molecular Medicine, Laboratory of Autoimmune Diagnostics, 6/8 Leo Tolstoy St, 197022 Saint Petersburg, Russia. · Federal Almazov Medical Research Centre, Saint Petersburg, Russia. · F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Grenzacherstrasse, Basel, Switzerland. · MS Center (City Clinical Hospital 31), Saint Petersburg, Russia. · Pubmed 27063622
2015
  • Sozialstiftung Bamberg Hospital, Bamberg, Germany. Electronic address: · Moscow MS Centre, Russian State Research Medical University named by NI Pirogov, Moscow, Russia. · Università di Roma Tor Vergata, Rome, Italy. · Tampere University Hospital, Tampere, Finland. · Blizard Institute, Bart׳s School of Medicine and Dentistry, London, UK. · General Faculty Hospital, Charles University, Prague, Czech Republic. · European Charcot Foundation, Molenhoek, The Netherlands. · Kliniken Valens, Valens, Switzerland. · European Health Economics, Spéracèdes, France. · Royal Holloway, University of London, Egham, UK. · CHUM Research Centre, Montreal, Quebec, Canada. · Western University, London, Ontario, Canada. · University Hospital San Carlos, Madrid, Spain. · Universitätsspital Zürich, Zürich, Switzerland. · Rehabilitation in MS (RIMS), Brussels, Belgium. · Northern Ireland Neurology Service, Portadown, UK. · University Hospital of Lille, Lille, France. · Pubmed 26008937
University College London
2017
  • Centre for Neuroscience and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK/Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. · Novartis Pharma AG, Basel, Switzerland. · Oxford PharmaGenesis, Oxford, UK. · Department of Neurology and Center of Clinical Neuroscience, Charles University, Prague, Czech Republic/First Faculty of Medicine, Charles University, Prague, Czech Republic/General University Hospital, Prague, Czech Republic. · Pubmed 28381105
2016
  • Department of Neurosciences, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. · Pubmed 27114560
  • Unit of Health-Care Epidemiology, Nuffield Department of Population Health, University of Oxford, Oxford, UK. · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary, University of London, London, UK; Department of Neurology, Barts Health NHS Trust, The Royal London Hospital, London, UK. · Unit of Health-Care Epidemiology, Nuffield Department of Population Health, University of Oxford, Oxford, UK · Pubmed 26857201
2015
  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Department of Neuroradiology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: · Pubmed 26195051
  • From the Neuroimmunology Unit (J.K., G.D., G.G.), Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK; Neurology, Departments of Medicine, Clinical Research and Biomedicine (J.K., J.L., L.K.), and the Medical Image Analysis Center (MIAC) (E.-W.R.), University Hospital, Basel, Switzerland; Novartis Pharmaceuticals Corporation (T.S., Y.C., G.F.), East Hanover, NJ; Novartis Pharma AG (F.D.), Basel, Switzerland; and Novartis Healthcare Pvt Ltd (A.S.), Hyderabad, India. · From the Neuroimmunology Unit (J.K., G.D., G.G.), Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK; Neurology, Departments of Medicine, Clinical Research and Biomedicine (J.K., J.L., L.K.), and the Medical Image Analysis Center (MIAC) (E.-W.R.), University Hospital, Basel, Switzerland; Novartis Pharmaceuticals Corporation (T.S., Y.C., G.F.), East Hanover, NJ; Novartis Pharma AG (F.D.), Basel, Switzerland; and Novartis Healthcare Pvt Ltd (A.S.), Hyderabad, India. · Pubmed 25809304
2014
  • From the Queen Mary University of London (G.G.), Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK; and the Department of Neurology (R.T.N.), Washington University School of Medicine, St. Louis, MO. · Pubmed 24610331
2017
  • From the Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General Hospital in Prague, Czech Republic; Neuroimmunology and Multiple Sclerosis Research, Department of Neurology (S.S.), University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Sanofi (D.H.M., K.T., M.C.C., D.J., M.A.P.), Cambridge, MA; Envision Scientific Solutions (P.X.), Philadelphia, PA; Envision Scientific Solutions (R.J.H.), Sydney, NSW, Australia; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · From the Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General Hospital in Prague, Czech Republic; Neuroimmunology and Multiple Sclerosis Research, Department of Neurology (S.S.), University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Sanofi (D.H.M., K.T., M.C.C., D.J., M.A.P.), Cambridge, MA; Envision Scientific Solutions (P.X.), Philadelphia, PA; Envision Scientific Solutions (R.J.H.), Sydney, NSW, Australia; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · Pubmed 28835403
  • From the Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Neuroimmunology and Multiple Sclerosis Research (S.S.), Department of Neurology, University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Department of Clinical Neurosciences (D.A.S.C., A.J.C.), University of Cambridge, UK; Sanofi (D.H.M., K.T., C.E.R., D.J., M.A.P.), Cambridge, MA; Evidence Scientific Solutions (R.J.H.), Sydney, NSW, Australia; and Evidence Scientific Solutions (P.X.), Philadelphia, PA. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · From the Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Neuroimmunology and Multiple Sclerosis Research (S.S.), Department of Neurology, University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Department of Clinical Neurosciences (D.A.S.C., A.J.C.), University of Cambridge, UK; Sanofi (D.H.M., K.T., C.E.R., D.J., M.A.P.), Cambridge, MA; Evidence Scientific Solutions (R.J.H.), Sydney, NSW, Australia; and Evidence Scientific Solutions (P.X.), Philadelphia, PA. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · Pubmed 28835401
  • From Neurologic Clinic and Policlinic (J.K., C.B., O.Y.), Departments of Medicine, Clinical Research, and Biomedicine, University Hospital Basel, University of Basel, Switzerland; Department of Neurology (B.N., E.W.), University of California San Francisco; Department of Neuroimmunology (D.G.), Queen Square, Institute of Neurology, London; independent statistician (S.M.), Haddenham, Bucks, UK; Department of Neurology (D.P.), University of Southern California, Los Angeles; and Department of Neuroscience and Trauma (G.G., S.G.), Queen Mary University of London, UK. · From Neurologic Clinic and Policlinic (J.K., C.B., O.Y.), Departments of Medicine, Clinical Research, and Biomedicine, University Hospital Basel, University of Basel, Switzerland; Department of Neurology (B.N., E.W.), University of California San Francisco; Department of Neuroimmunology (D.G.), Queen Square, Institute of Neurology, London; independent statistician (S.M.), Haddenham, Bucks, UK; Department of Neurology (D.P.), University of Southern California, Los Angeles; and Department of Neuroscience and Trauma (G.G., S.G.), Queen Mary University of London, UK. · Pubmed 28148632
2016
  • From NeuroRx Research (D.L.A.) and Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Department of Biomedical Engineering (E.F.) and Mellen Center (J.A.C.), Cleveland Clinic, OH; Zagreb Medical School and University Hospital Center (V.V.B.), Croatia; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Clinical Centre Kragujevac (M.S.), Clinic of Neurology, Serbia; Brigham and Women's Hospital Center for Neurologic Diseases (H.L.W.), Boston, MA; Sanofi Genzyme (S.L.L., D.H.M., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (D.R.T.), Horsham, West Sussex, UK. Dr. Panzara is currently with Wave Life Sciences, Cambridge, MA. · From NeuroRx Research (D.L.A.) and Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Department of Biomedical Engineering (E.F.) and Mellen Center (J.A.C.), Cleveland Clinic, OH; Zagreb Medical School and University Hospital Center (V.V.B.), Croatia; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Clinical Centre Kragujevac (M.S.), Clinic of Neurology, Serbia; Brigham and Women's Hospital Center for Neurologic Diseases (H.L.W.), Boston, MA; Sanofi Genzyme (S.L.L., D.H.M., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (D.R.T.), Horsham, West Sussex, UK. Dr. Panzara is currently with Wave Life Sciences, Cambridge, MA. · Pubmed 27590291
2015
  • From Neurology, the Departments of Medicine, Clinical Research and Biomedicine (L.K., T.D., Y.N., T.S.), the Medical Image Analysis Center (MIAC) (E.-W.R., T.S., N.M.-L.), and the Department of Radiology, Division of Neuroradiology (T.S.), University Hospital, University of Basel, Switzerland; the Department of Neuroscience (G.C.), Scientific Institute H. San Raffaele, University of Milan, Italy; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Royal Melbourne Hospital (H.B.), Parkville, Australia; the Department of Neurology (H.W.), University of Münster, Germany; the Neuroscience and Trauma Centre (G.G.), Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK; the Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Oxford PharmaGenesis Ltd. (S.G.), Tubney Warren Barns, Oxford, UK; Novartis Pharma AG (P.v.R., Y.Z., F.D., D.T.), Basel, Switzerland; and Novartis Pharmaceutical Corporation (R.G.), East Hanover, NJ. · From Neurology, the Departments of Medicine, Clinical Research and Biomedicine (L.K., T.D., Y.N., T.S.), the Medical Image Analysis Center (MIAC) (E.-W.R., T.S., N.M.-L.), and the Department of Radiology, Division of Neuroradiology (T.S.), University Hospital, University of Basel, Switzerland; the Department of Neuroscience (G.C.), Scientific Institute H. San Raffaele, University of Milan, Italy; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Royal Melbourne Hospital (H.B.), Parkville, Australia; the Department of Neurology (H.W.), University of Münster, Germany; the Neuroscience and Trauma Centre (G.G.), Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK; the Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Oxford PharmaGenesis Ltd. (S.G.), Tubney Warren Barns, Oxford, UK; Novartis Pharma AG (P.v.R., Y.Z., F.D., D.T.), Basel, Switzerland; and Novartis Pharmaceutical Corporation (R.G.), East Hanover, NJ. · Pubmed 26024899
2013
  • Department of Neuroinflammation, UCL Institute of Neurology, London, United Kingdom. · Pubmed 23936370
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Department of Neurology, University Hospital Basel, Basel, Switzerland. · Pubmed 23763388
  • Department of Neuroimmunology, Institute of Neurology, London, UK. · Pubmed 23495921
2012
  • Department of Neuroinflammation, UCL Institute of Neurology, Queen Mary University of London, Barts and the London School of Medicine and Dentistry, London E1 2AT, UK. · Pubmed 22258390
  • Department of Neuroimmunology, Institute of Neurology, London, UK. · Pubmed 22276904
2011
  • University College London, Institute of Neurology, London, UK. · Pubmed 21685230
2010
  • Institute of Neurology, University College London, London, United Kingdom. · Pubmed 20874249
  • Department of Neuroimmunology, UCL Institute of Neurology, Queen Square, London, United Kingdom. · Pubmed 21194151
2009
  • Department of Neuroinflammation, Institute of Neurology, UCL, Queen Square, London, UK. · Pubmed 19458321
University of Medicine and Dentistry of New Jersey
2017
  • Department of Neurology, University of Utah, Neurovirology Research Laboratory VASLCHCS, Imaging and Neuroscience Center, 175 North Medical Drive East, Salt Lake City, UT 84132, USA. Electronic address: · Department of Neurology, Queen Mary University London, The London School of Medicine and Dentistry, 4 Newark St, London, England, United Kingdom. Electronic address: · Department of Neurology, University of Münster, Schlossplatz 2, 48149 Münster, Germany. Electronic address: · Department of Neurology, Ruhr-University Bochum, Gudrunstr. 56, 44791 Bochum, Germany. Electronic address: · Department of Neurology, First Faculty of Medicine, Charles University in Prague, Kateřinská 30, 12821 Prague, Czech Republic. Electronic address: · Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research, Biomedicine, and Biomedical Engineering, University of Basel, Petersgraben 4, 4031 Basel, Switzerland. Electronic address: · Department of Neurology, Medical University of Łódź, Al. Kościuszki 4, 90-419 Łódź, Poland. Electronic address: · AbbVie Inc., 1400 Sheridan Rd, North Chicago, IL 60064, USA. Electronic address: · Biogen, 225 Binney St, Cambridge, MA 02142, USA. Electronic address: · AbbVie Biotherapeutics Inc., 1500 Seaport Blvd, Redwood City, CA 94063, USA. Electronic address: · AbbVie Inc., 1400 Sheridan Rd, North Chicago, IL 60064, USA. Electronic address: · Pubmed 29055471
2014
  • 1Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark St., London E1 2AT, UK. · Pubmed 24121462
2011
  • University of Medicine and Dentistry, New Jersey Medical School, Newark, NJ 07101, USA. · Pubmed 21228029
University of Basel
2015
  • From the Neuroimmunology Unit (J.K., G.D., G.G.), Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK; Neurology, Departments of Medicine, Clinical Research and Biomedicine (J.K., J.L., L.K.), and the Medical Image Analysis Center (MIAC) (E.-W.R.), University Hospital, Basel, Switzerland; Novartis Pharmaceuticals Corporation (T.S., Y.C., G.F.), East Hanover, NJ; Novartis Pharma AG (F.D.), Basel, Switzerland; and Novartis Healthcare Pvt Ltd (A.S.), Hyderabad, India. · From the Neuroimmunology Unit (J.K., G.D., G.G.), Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK; Neurology, Departments of Medicine, Clinical Research and Biomedicine (J.K., J.L., L.K.), and the Medical Image Analysis Center (MIAC) (E.-W.R.), University Hospital, Basel, Switzerland; Novartis Pharmaceuticals Corporation (T.S., Y.C., G.F.), East Hanover, NJ; Novartis Pharma AG (F.D.), Basel, Switzerland; and Novartis Healthcare Pvt Ltd (A.S.), Hyderabad, India. · Pubmed 25809304
2017
  • From Hospital Vall d'Hebron University, Barcelona (X.M.); University of California, San Francisco, San Francisco (S.L.H.), and Genentech, South San Francisco (D.M., H.G., P.C.) - both in California; University Hospital Basel, University of Basel (L.K.), and F. Hoffmann-La Roche (A.S., P.F., S.B., N.M.), Basel, Switzerland; McGill University (D.L.A., A.B.-O.) and NeuroRx Research (D.L.A.), Montreal, and University of British Columbia, Vancouver (A.T.) - both in Canada; University Vita-Salute San Raffaele, Milan (G.C.); University Hospital of Strasbourg, Clinical Investigation Center (INSERM Unité 1434), Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France (J.S.); Barts and the London School of Medicine and Dentistry, London (G.G.); Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf (H.-P.H.), and Technical University of Munich and Munich Cluster for Systems Neurology, Munich (B.H.) - both in Germany; Icahn School of Medicine at Mount Sinai, New York (F.L.); University of Miami, Miami (K.W.R.); Medical University of Łódź, Łódź, Poland (K.S.); and McGovern Medical School, University of Texas Health Science Center at Houston, Houston (J.S.W.). · Pubmed 28002688
  • From the University of California, San Francisco (S.L.H.), and Genentech, South San Francisco (D.M., P.C., H.G.) - both in California; McGill University (A.B.-O., D.L.A.) and NeuroRx Research (D.L.A.), Montreal, and University of British Columbia, Vancouver, BC (A.T.) - both in Canada; University Vita-Salute San Raffaele, Milan (G.C.); Barts and the London School of Medicine and Dentistry, London (G.G.); Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf (H.-P.H.), and the Technical University of Munich and Munich Cluster for Systems Neurology, Munich (B.H.) - both in Germany; Icahn School of Medicine at Mount Sinai, New York (F.L.); Hospital Vall d'Hebron University, Barcelona (X.M.); University of Miami, Miami (K.W.R.); Medical University of Lodz and Center for Neurology, Lodz, Poland (K.S.); McGovern Medical School, University of Texas Health Science Center at Houston, Houston (J.S.W.); and F. Hoffmann-La Roche (G.K., P.F., S.B., N.M.) and University Hospital Basel, University of Basel (L.K.), Basel, Switzerland. · Pubmed 28002679
  • From Neurologic Clinic and Policlinic (J.K., C.B., O.Y.), Departments of Medicine, Clinical Research, and Biomedicine, University Hospital Basel, University of Basel, Switzerland; Department of Neurology (B.N., E.W.), University of California San Francisco; Department of Neuroimmunology (D.G.), Queen Square, Institute of Neurology, London; independent statistician (S.M.), Haddenham, Bucks, UK; Department of Neurology (D.P.), University of Southern California, Los Angeles; and Department of Neuroscience and Trauma (G.G., S.G.), Queen Mary University of London, UK. · From Neurologic Clinic and Policlinic (J.K., C.B., O.Y.), Departments of Medicine, Clinical Research, and Biomedicine, University Hospital Basel, University of Basel, Switzerland; Department of Neurology (B.N., E.W.), University of California San Francisco; Department of Neuroimmunology (D.G.), Queen Square, Institute of Neurology, London; independent statistician (S.M.), Haddenham, Bucks, UK; Department of Neurology (D.P.), University of Southern California, Los Angeles; and Department of Neuroscience and Trauma (G.G., S.G.), Queen Mary University of London, UK. · Pubmed 28148632
2015
  • From Neurology, the Departments of Medicine, Clinical Research and Biomedicine (L.K., T.D., Y.N., T.S.), the Medical Image Analysis Center (MIAC) (E.-W.R., T.S., N.M.-L.), and the Department of Radiology, Division of Neuroradiology (T.S.), University Hospital, University of Basel, Switzerland; the Department of Neuroscience (G.C.), Scientific Institute H. San Raffaele, University of Milan, Italy; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Royal Melbourne Hospital (H.B.), Parkville, Australia; the Department of Neurology (H.W.), University of Münster, Germany; the Neuroscience and Trauma Centre (G.G.), Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK; the Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Oxford PharmaGenesis Ltd. (S.G.), Tubney Warren Barns, Oxford, UK; Novartis Pharma AG (P.v.R., Y.Z., F.D., D.T.), Basel, Switzerland; and Novartis Pharmaceutical Corporation (R.G.), East Hanover, NJ. · From Neurology, the Departments of Medicine, Clinical Research and Biomedicine (L.K., T.D., Y.N., T.S.), the Medical Image Analysis Center (MIAC) (E.-W.R., T.S., N.M.-L.), and the Department of Radiology, Division of Neuroradiology (T.S.), University Hospital, University of Basel, Switzerland; the Department of Neuroscience (G.C.), Scientific Institute H. San Raffaele, University of Milan, Italy; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Royal Melbourne Hospital (H.B.), Parkville, Australia; the Department of Neurology (H.W.), University of Münster, Germany; the Neuroscience and Trauma Centre (G.G.), Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK; the Department of Neurology (H.-P.H.), Heinrich Heine University, Düsseldorf, Germany; Oxford PharmaGenesis Ltd. (S.G.), Tubney Warren Barns, Oxford, UK; Novartis Pharma AG (P.v.R., Y.Z., F.D., D.T.), Basel, Switzerland; and Novartis Pharmaceutical Corporation (R.G.), East Hanover, NJ. · Pubmed 26024899
  • Neurology, University Hospital, Basel, Switzerland. · Pubmed 25557371
2014
  • Departments of Neurology and Biomedicine, University Hospital Basel, Switzerland. · Pubmed 24150779
2013
  • Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Department of Neurology, University Hospital Basel, Basel, Switzerland. · Pubmed 23763388
Washington University
2014
  • From the Queen Mary University of London (G.G.), Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK; and the Department of Neurology (R.T.N.), Washington University School of Medicine, St. Louis, MO. · Pubmed 24610331
2010
  • Department of Neurology, Washington University in St Louis, Saint Louis, MO 63110, USA. · Pubmed 20298967
49 Other Locations Show
Yearly article counts 32328242527291923127
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.